| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.82e-08 | 14 | 313 | 6 | GO:0005130 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 8.13e-07 | 34 | 313 | 7 | GO:0015125 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 SLCO1C1 PSG8 GRIA1 SLC1A6 SLC1A7 SLC7A9 SLC6A12 CTNS SLC38A6 SLC26A6 | 1.01e-06 | 207 | 313 | 15 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 SLCO1C1 PSG8 GRIA1 SLC1A6 SLC1A7 SLC7A9 SLC6A12 CTNS SLC38A6 SLC26A6 | 1.08e-06 | 208 | 313 | 15 | GO:0005342 |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.14e-06 | 23 | 313 | 6 | GO:0034235 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 SLCO1C1 PSG8 SLC5A1 SLC5A11 | 1.43e-06 | 70 | 313 | 9 | GO:1901618 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA2 CEACAM5 PSG4 PSG6 PKD1L1 CEACAM6 SLC15A3 RYR1 SLC39A13 CEACAM1 SLCO1C1 SCN1A PSG8 TMCO3 KCNT1 MCOLN2 SLC5A9 GRIA1 FLVCR2 GSDMC SLC1A6 SLC47A2 SLC1A7 SLC2A3 SLC5A1 SLC30A6 SLC7A9 SLC5A11 SLC6A12 P2RX1 SLC22A5 APOL3 SLC28A2 LRP5 ABCC12 CTNS HTR3B SLC38A6 SLC26A6 CACNA2D3 SLC25A45 | 1.45e-06 | 1180 | 313 | 41 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ABCA2 CEACAM5 PSG4 PSG6 PKD1L1 CEACAM6 SLC15A3 RYR1 SLC39A13 CEACAM1 SLCO1C1 SCN1A PSG8 TMCO3 KCNT1 MCOLN2 SLC5A9 GRIA1 NPC2 APOB FLVCR2 GSDMC SLC1A6 SLC47A2 SLC1A7 SLC2A3 SLC5A1 SLC30A6 SLC7A9 SLC5A11 SLC6A12 P2RX1 SLC22A5 APOL3 SLC28A2 LRP5 ABCC12 CTNS HTR3B SLC38A6 SLC26A6 CACNA2D3 SLC25A45 | 2.26e-06 | 1289 | 313 | 43 | GO:0005215 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.96e-06 | 29 | 313 | 6 | GO:0035325 | |
| GeneOntologyMolecularFunction | filamin binding | 4.96e-06 | 29 | 313 | 6 | GO:0031005 | |
| GeneOntologyMolecularFunction | galactoside binding | 7.01e-06 | 9 | 313 | 4 | GO:0016936 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 SLCO1C1 PSG8 SLC6A12 SLC26A6 | 1.18e-05 | 90 | 313 | 9 | GO:0008028 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 SLCO1C1 PSG8 GRIA1 SLC1A6 SLC1A7 SLC2A3 SLC7A9 SLC6A12 CTNS SLC38A6 SLC26A6 | 1.70e-05 | 293 | 313 | 16 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC15A3 SLCO1C1 TMCO3 SLC5A9 SLC1A6 SLC47A2 SLC1A7 SLC5A1 SLC30A6 SLC7A9 SLC5A11 SLC6A12 SLC22A5 SLC28A2 CTNS SLC26A6 | 1.92e-05 | 296 | 313 | 16 | GO:0015291 |
| GeneOntologyMolecularFunction | phosphatase binding | CEACAM5 PSG4 MFHAS1 PSG6 CEACAM6 MAP3K5 CEACAM1 DLG2 DLG3 PSG8 ANAPC4 SPTBN4 SMAD2 SMAD3 | 7.81e-05 | 264 | 313 | 14 | GO:0019902 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC15A3 SLC5A9 SLC1A6 SLC1A7 SLC5A1 SLC5A11 SLC6A12 SLC28A2 CTNS | 1.09e-04 | 119 | 313 | 9 | GO:0015294 |
| GeneOntologyMolecularFunction | glycolipid binding | 1.12e-04 | 49 | 313 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | CEACAM5 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 ITGAX CEACAM1 PSG8 DSCAM | 1.24e-04 | 149 | 313 | 10 | GO:1990782 |
| GeneOntologyMolecularFunction | disaccharide binding | 1.27e-04 | 7 | 313 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 1.27e-04 | 7 | 313 | 3 | GO:0005412 | |
| GeneOntologyMolecularFunction | symporter activity | SLC15A3 SLC5A9 SLC1A6 SLC1A7 SLC5A1 SLC5A11 SLC6A12 SLC22A5 SLC28A2 CTNS | 1.31e-04 | 150 | 313 | 10 | GO:0015293 |
| GeneOntologyMolecularFunction | calcium ion binding | MATN1 PCDHB5 DGKB ITGA5 PLA2G4D ZZEF1 RYR1 ADGRE3 PCDH15 NID2 FAT4 CLEC6A DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 LALBA SYT2 RET PPEF2 PCDH20 CRB1 SNED1 PCDHGA12 PCDH7 | 1.38e-04 | 749 | 313 | 26 | GO:0005509 |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.46e-04 | 73 | 313 | 7 | GO:0170055 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCA2 CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 SLCO1C1 PSG8 NPC2 APOB APOL3 | 2.79e-04 | 196 | 313 | 11 | GO:0005319 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.80e-04 | 81 | 313 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 4.14e-04 | 23 | 313 | 4 | GO:0030215 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 4.16e-04 | 173 | 313 | 10 | GO:0070851 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | PKD1L1 RYR1 SLC39A13 SCN1A TMCO3 KCNT1 MCOLN2 SLC5A9 GRIA1 SLC1A6 SLC1A7 SLC5A1 SLC30A6 SLC5A11 SLC6A12 P2RX1 SLC28A2 CACNA2D3 | 4.23e-04 | 465 | 313 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | protein phosphatase binding | CEACAM5 PSG4 MFHAS1 PSG6 CEACAM6 MAP3K5 CEACAM1 DLG2 DLG3 PSG8 ANAPC4 | 5.01e-04 | 210 | 313 | 11 | GO:0019903 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA2 SLC15A3 SLCO1C1 TMCO3 SLC5A9 SLC1A6 SLC47A2 SLC1A7 SLC5A1 SLC30A6 SLC7A9 SLC5A11 SLC6A12 SLC22A5 SLC28A2 ABCC12 CTNS SLC26A6 | 5.71e-04 | 477 | 313 | 18 | GO:0022804 |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 5.78e-04 | 25 | 313 | 4 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 5.78e-04 | 25 | 313 | 4 | GO:0055056 | |
| GeneOntologyMolecularFunction | phospholipase D activator activity | 7.27e-04 | 3 | 313 | 2 | GO:1990583 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 7.82e-04 | 27 | 313 | 4 | GO:0015145 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | MATN1 COL6A5 FGL2 COL5A1 NID2 COL6A2 FRAS1 COL12A1 TECTB TECTA | 7.94e-04 | 188 | 313 | 10 | GO:0005201 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | PKD1L1 SLC15A3 RYR1 SLC39A13 SCN1A TMCO3 KCNT1 MCOLN2 SLC5A9 GRIA1 SLC1A6 SLC47A2 SLC1A7 SLC5A1 SLC30A6 SLC5A11 SLC6A12 P2RX1 SLC28A2 CTNS HTR3B CACNA2D3 | 8.37e-04 | 664 | 313 | 22 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | PKD1L1 SLC15A3 RYR1 SLC39A13 SCN1A TMCO3 KCNT1 MCOLN2 SLC5A9 GRIA1 SLC1A6 SLC47A2 SLC1A7 SLC5A1 SLC30A6 SLC5A11 SLC6A12 P2RX1 SLC28A2 CTNS CACNA2D3 | 9.55e-04 | 627 | 313 | 21 | GO:0022890 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC15A3 TMCO3 SLC5A9 SLC1A6 SLC47A2 SLC1A7 SLC5A1 SLC30A6 SLC5A11 SLC6A12 SLC28A2 CTNS SLC26A6 | 9.88e-04 | 301 | 313 | 13 | GO:0022853 |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.03e-03 | 29 | 313 | 4 | GO:0051119 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 1.03e-03 | 29 | 313 | 4 | GO:0045499 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.18e-03 | 30 | 313 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.19e-03 | 103 | 313 | 7 | GO:0004553 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.33e-03 | 31 | 313 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.33e-03 | 31 | 313 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.33e-03 | 105 | 313 | 7 | GO:0015171 | |
| GeneOntologyMolecularFunction | protein kinase binding | CEACAM5 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 ITGAX RHOU MAP3K5 CEACAM1 PTPN6 RPTOR DLG2 DLG3 PSG8 RAB13 DSCAM GRIA1 UFL1 SPG11 PPEF2 FAF1 PRKG2 TBR1 TOP2A SMAD3 | 1.37e-03 | 873 | 313 | 26 | GO:0019901 |
| GeneOntologyMolecularFunction | myo-inositol transmembrane transporter activity | 1.44e-03 | 4 | 313 | 2 | GO:0005365 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 1.44e-03 | 4 | 313 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | L-cystine transmembrane transporter activity | 1.44e-03 | 4 | 313 | 2 | GO:0015184 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 1.44e-03 | 4 | 313 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 1.44e-03 | 4 | 313 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | beta-glucuronidase activity | 1.44e-03 | 4 | 313 | 2 | GO:0004566 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 1.44e-03 | 4 | 313 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 1.51e-03 | 15 | 313 | 3 | GO:0005313 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | PKD1L1 SLC15A3 RYR1 SLC39A13 SCN1A TMCO3 KCNT1 MCOLN2 SLC5A9 GRIA1 SLC1A6 SLC47A2 SLC1A7 SLC5A1 SLC30A6 SLC5A11 SLC6A12 P2RX1 APOL3 SLC28A2 CTNS HTR3B SLC26A6 CACNA2D3 | 1.69e-03 | 793 | 313 | 24 | GO:0015075 |
| GeneOntologyMolecularFunction | collagen binding | 1.71e-03 | 81 | 313 | 6 | GO:0005518 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | PKD1L1 SLC15A3 RYR1 SLC39A13 SCN1A TMCO3 KCNT1 MCOLN2 SLC5A9 GRIA1 SLC1A6 SLC47A2 SLC1A7 SLC5A1 SLC30A6 SLC5A11 SLC6A12 P2RX1 APOL3 SLC28A2 CTNS SLC26A6 CACNA2D3 | 2.03e-03 | 758 | 313 | 23 | GO:0015318 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 2.20e-03 | 17 | 313 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 2.37e-03 | 5 | 313 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 2.37e-03 | 5 | 313 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 2.66e-03 | 61 | 313 | 5 | GO:0008408 | |
| GeneOntologyMolecularFunction | kinase binding | CEACAM5 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 ITGAX RHOU MAP3K5 CEACAM1 PTPN6 RPTOR DLG2 DLG3 PSG8 RAB13 DSCAM GRIA1 UFL1 SPG11 PPEF2 SLC2A3 FAF1 PRKG2 TBR1 TOP2A SMAD3 | 2.85e-03 | 969 | 313 | 27 | GO:0019900 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ITGA5 ITGAL ITGAX DSCAML1 FAP PTPN6 MRTFB PTPRZ1 AHNAK CNTN5 NOS3 COL5A1 DSC2 DSCAM ITGA8 ADGRL1 EPHA2 EIF4G2 LRRFIP1 | 3.02e-03 | 599 | 313 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | exonuclease activity | 3.26e-03 | 92 | 313 | 6 | GO:0004527 | |
| GeneOntologyMolecularFunction | galactose transmembrane transporter activity | 3.52e-03 | 6 | 313 | 2 | GO:0005354 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 3.57e-03 | 20 | 313 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 3.57e-03 | 20 | 313 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 3.80e-03 | 41 | 313 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | RAB19 MFHAS1 RHOU SEPTIN6 RAB13 RAP2A RAP2B LRRK1 NKIRAS1 ARF1 ARF3 ARF4 ARF5 PRKG2 RAP2C | 4.12e-03 | 439 | 313 | 15 | GO:0019001 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | RAB19 MFHAS1 RHOU SEPTIN6 RAB13 RAP2A RAP2B LRRK1 NKIRAS1 ARF1 ARF3 ARF4 ARF5 PRKG2 RAP2C | 4.12e-03 | 439 | 313 | 15 | GO:0032561 |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 4.15e-03 | 42 | 313 | 4 | GO:0015144 | |
| GeneOntologyMolecularFunction | GTP binding | RAB19 MFHAS1 RHOU SEPTIN6 RAB13 RAP2A RAP2B LRRK1 NKIRAS1 ARF1 ARF3 ARF4 ARF5 RAP2C | 4.18e-03 | 397 | 313 | 14 | GO:0005525 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 PCDHB5 CEACAM6 ITGA5 ITGAL DSCAML1 CEACAM1 CNTN5 PCDH15 PSG8 FAT4 DSC2 DSCAM PCDHGB7 FAT3 PCDHB14 PCDHB9 ADGRL1 LRRC4B RET PCDH20 CRB1 LGALS9 PCDHGA12 PCDH7 | 6.67e-15 | 313 | 312 | 29 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 PSG4 PSG6 PCDHB5 CEACAM6 DSCAML1 CEACAM1 CNTN5 PCDH15 PSG8 FAT4 DSC2 DSCAM PCDHGB7 FAT3 PCDHB14 PCDHB9 RET PCDH20 PCDHGA12 PCDH7 | 9.86e-13 | 187 | 312 | 21 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 PCDHB5 PKD1L1 CEACAM6 ITGA5 ITGAL ITGAX DSCAML1 CEACAM1 FGL2 PTPN6 CNTN5 PCDH15 DLG2 DLG3 PSG8 FAT4 RAP2B DSC2 DSCAM PCDHGB7 FAT3 PCDHB14 PCDHB9 SLFN12 ITGA8 ADGRL1 LRRC4B UFL1 RET TEK PCDH20 CYFIP2 CRB1 LGALS9 PCDHGA12 TNFSF13B LRP5 PCDH7 | 5.92e-09 | 1077 | 312 | 43 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PSG8 LGALS9 | 6.69e-09 | 40 | 312 | 9 | GO:0045953 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PSG8 LGALS9 | 8.46e-09 | 41 | 312 | 9 | GO:0002716 |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.64e-08 | 21 | 312 | 7 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.64e-08 | 21 | 312 | 7 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PSG8 LGALS9 | 3.04e-08 | 47 | 312 | 9 | GO:0001911 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 3.10e-08 | 14 | 312 | 6 | GO:0070348 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | LGALS9C CEACAM5 LGALS9B CEACAM6 ITGA5 ITGAL FAT4 ADGRL1 CRB1 LGALS9 | 3.42e-08 | 63 | 312 | 10 | GO:0007157 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 UFL1 LGALS9 | 4.88e-08 | 83 | 312 | 11 | GO:0002707 |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 5.10e-08 | 15 | 312 | 6 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 5.10e-08 | 15 | 312 | 6 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.10e-08 | 15 | 312 | 6 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 5.10e-08 | 15 | 312 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PSG8 LGALS9 | 7.68e-08 | 52 | 312 | 9 | GO:0031342 |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 8.05e-08 | 16 | 312 | 6 | GO:0038016 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP CEACAM21 PSG8 NOS3 KNG1 | 8.39e-08 | 69 | 312 | 10 | GO:0030195 |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP CEACAM21 PSG8 NOS3 KNG1 | 9.66e-08 | 70 | 312 | 10 | GO:1900047 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.16e-07 | 27 | 312 | 7 | GO:0070344 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.23e-07 | 17 | 312 | 6 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.23e-07 | 17 | 312 | 6 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.23e-07 | 17 | 312 | 6 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP CEACAM21 PSG8 NOS3 KNG1 | 1.27e-07 | 72 | 312 | 10 | GO:0050819 |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.82e-07 | 18 | 312 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 UFL1 LGALS9 | 2.24e-07 | 96 | 312 | 11 | GO:0002704 |
| GeneOntologyBiologicalProcess | behavior | MORC1 ABCA2 B4GALNT1 CEACAM5 PSG4 PSG6 CEACAM6 ITGA5 ZZEF1 CEACAM1 PTPRZ1 RPTOR SCN1A VPS13A PCDH15 PSG8 ADGRF1 DSCAM CPEB3 APBA2 ITGA8 GRIA1 CHD8 SPG11 NCSTN CREB1 ARF4 SPTBN4 P2RX1 IFT88 SLC22A5 CSTB CTNS TBR1 GAA | 2.59e-07 | 891 | 312 | 35 | GO:0007610 |
| GeneOntologyBiologicalProcess | cell junction organization | CEACAM5 PSG4 PSG6 SPTB PCDHB5 DGKB CEACAM6 PLXND1 ITGA5 CEACAM1 CNTN5 AFG3L2 DLG2 PSG8 CLDN34 ADGRF1 RAB13 RAP2A DSCAM PCDHB14 PCDHB9 CPEB3 GRIA1 ADGRL1 LRRC4B SPG11 TEK ARF1 CYFIP2 ARF4 VANGL2 SPTBN4 EPHA2 LRP5 CACNA2D3 SMAD3 SEMA3E | 2.62e-07 | 974 | 312 | 37 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP CEACAM21 PSG8 NOS3 KNG1 SMAD3 | 2.77e-07 | 98 | 312 | 11 | GO:0061045 |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | LGALS9C ERBB3 CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 PLXND1 DSCAML1 CEACAM1 FGL2 PTPN6 PTPRZ1 PSG8 KNG1 DSCAM SLFN12 SEMA5A UFL1 LGALS9 SEMA3E | 3.07e-07 | 375 | 312 | 21 | GO:0007162 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 3.26e-07 | 31 | 312 | 7 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.70e-07 | 20 | 312 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 4.12e-07 | 32 | 312 | 7 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP PTPN6 CEACAM21 PSG8 NOS3 KNG1 SMAD3 | 4.86e-07 | 126 | 312 | 12 | GO:1903035 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 5.12e-07 | 21 | 312 | 6 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 SLFN12 LGALS9 | 6.79e-07 | 107 | 312 | 11 | GO:0042130 |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 6.95e-07 | 22 | 312 | 6 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 9.28e-07 | 23 | 312 | 6 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 9.28e-07 | 23 | 312 | 6 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP CEACAM21 PSG8 NOS3 KNG1 | 1.18e-06 | 91 | 312 | 10 | GO:0030193 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.22e-06 | 24 | 312 | 6 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.22e-06 | 24 | 312 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.22e-06 | 24 | 312 | 6 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP CEACAM21 PSG8 NOS3 KNG1 | 1.45e-06 | 93 | 312 | 10 | GO:1900046 |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 FGL2 PTPN6 PSG8 UFL1 LGALS9 PRKDC | 1.54e-06 | 166 | 312 | 13 | GO:0002698 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.59e-06 | 25 | 312 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.59e-06 | 25 | 312 | 6 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP CEACAM21 PSG8 NOS3 KNG1 | 1.94e-06 | 96 | 312 | 10 | GO:0050818 |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 FGL2 PTPN6 PSG8 SLFN12 UFL1 LGALS9 | 2.15e-06 | 171 | 312 | 13 | GO:0050868 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PSG8 LGALS9 | 2.16e-06 | 76 | 312 | 9 | GO:0042269 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 SLFN12 LGALS9 | 2.95e-06 | 124 | 312 | 11 | GO:0050672 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 3.25e-06 | 28 | 312 | 6 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PSG8 LGALS9 | 3.34e-06 | 80 | 312 | 9 | GO:0002715 |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 SLFN12 LGALS9 | 3.45e-06 | 126 | 312 | 11 | GO:0032945 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 4.04e-06 | 29 | 312 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 LGALS9 | 4.41e-06 | 105 | 312 | 10 | GO:0042267 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 LGALS9 | 6.17e-06 | 109 | 312 | 10 | GO:0002228 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 SLFN12 LGALS9 | 6.27e-06 | 134 | 312 | 11 | GO:0070664 |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 6.34e-06 | 47 | 312 | 7 | GO:0015721 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 6.74e-06 | 87 | 312 | 9 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 7.43e-06 | 32 | 312 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 7.43e-06 | 32 | 312 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 FGL2 PTPN6 PSG8 SLFN12 UFL1 LGALS9 | 7.68e-06 | 192 | 312 | 13 | GO:1903038 |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 8.44e-06 | 49 | 312 | 7 | GO:0002837 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | CEACAM5 PSG4 PSG6 MATN1 CEACAM6 PLXND1 ITGAX DSCAML1 RYR1 CEACAM1 HOXC8 MRTFB PCDH15 PSG8 USH2A NOS3 CARM1 COL5A1 SEMA3C FAT4 FRAS1 DSCAM FAT3 TSPEAR ITGA8 TECTA TEK CRB1 ADGRG6 VANGL2 IFT88 EPHA2 ZNF335 NR5A2 LRP5 CTNS TBR1 GAA SMAD2 SMAD3 | 8.77e-06 | 1269 | 312 | 40 | GO:0009887 |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 8.96e-06 | 33 | 312 | 6 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 8.96e-06 | 33 | 312 | 6 | GO:0030852 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 9.69e-06 | 50 | 312 | 7 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.07e-05 | 34 | 312 | 6 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.07e-05 | 34 | 312 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.28e-05 | 35 | 312 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 1.36e-05 | 4 | 312 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | positive regulation of striated muscle tissue development | 1.36e-05 | 4 | 312 | 3 | GO:0045844 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle organ development | 1.36e-05 | 4 | 312 | 3 | GO:0048636 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 PCDH15 PSG8 USH2A NOS3 LRRK1 TEX15 CREB1 CRB1 STRAP SLC22A5 SLC28A2 ATF1 | 1.47e-05 | 334 | 312 | 17 | GO:0060249 |
| GeneOntologyBiologicalProcess | tissue homeostasis | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 PCDH15 PSG8 USH2A NOS3 LRRK1 TEX15 CREB1 CRB1 STRAP SLC22A5 SLC28A2 ATF1 | 1.47e-05 | 334 | 312 | 17 | GO:0001894 |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 FGL2 PSG8 UFL1 LGALS9 | 1.95e-05 | 151 | 312 | 11 | GO:0002832 |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.08e-05 | 56 | 312 | 7 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.10e-05 | 38 | 312 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 FGL2 PTPN6 PSG8 SLFN12 UFL1 LGALS9 | 2.11e-05 | 211 | 312 | 13 | GO:0051250 |
| GeneOntologyBiologicalProcess | wound healing | ERBB3 CEACAM5 PSG4 PSG6 DGKB CEACAM6 ITGA5 CEACAM1 FAP PTPN6 CEACAM21 AHNAK PSG8 NOS3 KNG1 COL5A1 RAP2B VANGL2 P2RX1 SYTL4 SMAD3 | 2.21e-05 | 493 | 312 | 21 | GO:0042060 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 2.45e-05 | 39 | 312 | 6 | GO:0045717 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of epithelial cell apical/basal polarity | 2.63e-05 | 58 | 312 | 7 | GO:0045197 | |
| GeneOntologyBiologicalProcess | platelet activation | CEACAM5 PSG4 PSG6 DGKB CEACAM6 CEACAM1 PTPN6 PSG8 NOS3 RAP2B P2RX1 | 2.98e-05 | 158 | 312 | 11 | GO:0030168 |
| GeneOntologyBiologicalProcess | regulation of striated muscle tissue development | 3.18e-05 | 25 | 312 | 5 | GO:0016202 | |
| GeneOntologyBiologicalProcess | circulatory system development | ERBB3 CEACAM5 PSG4 PSG6 PKD1L1 CEACAM6 PLXND1 ITGA5 ITGAX RYR1 CEACAM1 FREM2 FAP PTPN6 MRTFB FDPS PSG8 NOS3 COL5A1 SEMA3C FAT4 AGGF1 SEMA5A APOB FLVCR2 TEK ADAM12 CREB1 ADGRG6 VANGL2 OR10J5 IFT88 LOX EPHA2 SLC22A5 EIF4G2 LRP5 PRKDC GAA SMAD2 SMAD3 SEMA3E | 3.36e-05 | 1442 | 312 | 42 | GO:0072359 |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | LGALS9C CEACAM5 LGALS9B PSG4 MFHAS1 PSG6 CEACAM6 CEACAM1 FGL2 FAP PTPN6 CEACAM21 PSG8 NOS3 KNG1 SEMA5A CHD8 TEK LGALS9 C1QTNF12 SMAD3 | 3.52e-05 | 509 | 312 | 21 | GO:0032102 |
| GeneOntologyBiologicalProcess | T cell proliferation | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 ITGAL ITGAX CEACAM1 PTPN6 PSG8 SLFN12 NCSTN LGALS9 TNFSF13B | 3.58e-05 | 288 | 312 | 15 | GO:0042098 |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 3.67e-05 | 61 | 312 | 7 | GO:0060259 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 ZBTB7A RPTOR PSG8 LRRK1 CREB1 EPHA2 | 3.75e-05 | 162 | 312 | 11 | GO:0030316 |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 3.79e-05 | 42 | 312 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of bipolar cell polarity | 4.54e-05 | 63 | 312 | 7 | GO:0061245 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of apical/basal cell polarity | 4.54e-05 | 63 | 312 | 7 | GO:0035088 | |
| GeneOntologyBiologicalProcess | blood coagulation | CEACAM5 PSG4 PSG6 DGKB CEACAM6 CEACAM1 FAP PTPN6 CEACAM21 PSG8 NOS3 KNG1 RAP2B P2RX1 | 4.54e-05 | 260 | 312 | 14 | GO:0007596 |
| GeneOntologyBiologicalProcess | regulation of wound healing | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP CEACAM21 PSG8 NOS3 KNG1 SMAD3 | 4.69e-05 | 166 | 312 | 11 | GO:0061041 |
| GeneOntologyBiologicalProcess | synapse organization | SPTB PCDHB5 DGKB PLXND1 CNTN5 AFG3L2 DLG2 ADGRF1 RAP2A DSCAM PCDHB14 PCDHB9 CPEB3 GRIA1 ADGRL1 LRRC4B SPG11 ARF1 CYFIP2 ARF4 VANGL2 SPTBN4 LRP5 CACNA2D3 SEMA3E | 4.87e-05 | 685 | 312 | 25 | GO:0050808 |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | ERBB3 CEACAM5 PSG4 PSG6 CEACAM6 ERBIN CEACAM1 ADGRE3 PSG8 ARF4 | 5.18e-05 | 139 | 312 | 10 | GO:0007173 |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | LGALS9C CEACAM5 LGALS9B PSG4 PSG6 CEACAM6 CEACAM1 FGL2 PTPN6 PSG8 NOS3 SLFN12 UFL1 LGALS9 | 5.36e-05 | 264 | 312 | 14 | GO:0050866 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | ERBB3 CEACAM5 PSG4 MFHAS1 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 SEMA5A RET TEK LOX EPHA2 C1QTNF12 SEMA3E | 5.41e-05 | 334 | 312 | 16 | GO:0051896 |
| GeneOntologyBiologicalProcess | circulatory system process | ABCA2 CEACAM5 PSG4 PSG6 GPR37L1 CEACAM6 CEACAM1 KL SLCO1C1 SCN1A PSG8 NOS3 KNG1 DSC2 NDST2 TEK SLC2A3 SLC5A1 SPTBN4 P2RX1 SLC22A5 SLC28A2 LRP5 CORIN GAA SMAD3 | 5.51e-05 | 733 | 312 | 26 | GO:0003013 |
| GeneOntologyCellularComponent | anchoring junction | CEACAM5 RPLP0 PSG4 PSG6 PCDHB5 CEACAM6 SRP68 ITGA5 ITGAL ERBIN RHOU CEACAM1 FAP PTPN6 AHNAK SCN1A DLG2 DLG3 PSG8 CLDN34 RAB13 RAP2B HYOU1 DSC2 ITGA8 GRIA1 NCSTN TEK ARF1 CRB1 SLC5A1 VANGL2 SPTBN4 PCDHGA12 EPHA2 TNFSF13B EIF4G2 RAP2C | 6.78e-08 | 976 | 312 | 38 | GO:0070161 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 7.44e-08 | 16 | 312 | 6 | GO:0070021 | |
| GeneOntologyCellularComponent | cell-cell junction | CEACAM5 PSG4 PSG6 PCDHB5 CEACAM6 ITGA5 ITGAL CEACAM1 PTPN6 AHNAK SCN1A DLG2 DLG3 PSG8 CLDN34 RAB13 RAP2B DSC2 GRIA1 TEK CRB1 SLC5A1 VANGL2 SPTBN4 PCDHGA12 EPHA2 EIF4G2 RAP2C | 8.24e-08 | 591 | 312 | 28 | GO:0005911 |
| GeneOntologyCellularComponent | cell projection membrane | CEACAM5 PSG4 PSG6 PKD1L1 GPR37L1 CEACAM6 PLXND1 ITGA5 CEACAM1 FAP PTPRZ1 PSG8 USH2A TSPEAR ITGA8 GRIA1 ARF4 SLC5A1 SLC7A9 EPHA2 SLC22A5 SLC28A2 SLC26A6 | 1.55e-07 | 431 | 312 | 23 | GO:0031253 |
| GeneOntologyCellularComponent | apical part of cell | ERBB3 CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 FAP KL CEACAM21 BTD PSG8 USH2A NOS3 FAT4 ITGA8 TEK SLC47A2 CRB1 SLC5A1 VANGL2 SLC7A9 SLC5A11 SYTL4 SLC22A5 PRKG2 SLC26A6 | 1.02e-06 | 592 | 312 | 26 | GO:0045177 |
| GeneOntologyCellularComponent | cell surface | HYAL4 CEACAM5 BTNL8 PSG4 PSG6 PSG7 SPTB CEACAM3 CEACAM6 ITGA5 ITGAL ZZEF1 ITGAX DSCAML1 MAP3K5 CEACAM1 FAP KISS1R CEACAM21 BTNL3 ADGRE3 PSG8 IGSF3 NID2 CLEC6A FOLH1 ZPLD1 TECTB TSPEAR ITGA8 GRIA1 TEK ADGRG6 P2RX1 EPHA2 CORIN HTR3B | 4.31e-06 | 1111 | 312 | 37 | GO:0009986 |
| GeneOntologyCellularComponent | external encapsulating structure | LGALS9C LGALS9B MATN1 COL6A5 ERBIN FGL2 COLEC12 FREM2 PTPRZ1 PZP USH2A KNG1 COL5A1 NID2 COL6A2 SEMA3C FRAS1 COL12A1 TECTB TECTA PKHD1L1 LGALS9 SNED1 P3H2 LOX CSTB | 6.97e-06 | 658 | 312 | 26 | GO:0030312 |
| GeneOntologyCellularComponent | vesicle membrane | ABCA2 CEACAM3 CEACAM6 PLD3 SLC15A3 ITGAL WASHC2A ITGAX RHOU SLC39A13 CEACAM1 COLEC12 ADGRE3 VPS13A SEC16A DLG2 NOS3 RAB13 MCOLN2 RAP2A RAP2B WASHC2C ZPLD1 STXBP5 GRIA1 COPG2 APOB SYT2 NCSTN RET SLC2A3 P2RX1 IFT88 SYTL4 SLC28A2 CTNS RAP2C PCDH7 SLC26A6 GAA UEVLD | 7.58e-06 | 1325 | 312 | 41 | GO:0012506 |
| GeneOntologyCellularComponent | receptor complex | ERBB3 CEACAM5 PSG4 PSG6 GPR37L1 CEACAM6 PLXND1 ITGA5 ITGAL ITGAX CEACAM1 PTPN6 DLG3 PSG8 STXBP5 ITGA8 GRIA1 RET TEK SACM1L EPHA2 LRP5 HTR3B SMAD3 | 7.63e-06 | 581 | 312 | 24 | GO:0043235 |
| GeneOntologyCellularComponent | lateral plasma membrane | 8.02e-06 | 90 | 312 | 9 | GO:0016328 | |
| GeneOntologyCellularComponent | secretory granule membrane | CEACAM3 CEACAM6 ITGAL ITGAX CEACAM1 ADGRE3 RAP2B STXBP5 SYT2 NCSTN SLC2A3 P2RX1 IFT88 SYTL4 RAP2C PCDH7 GAA | 1.02e-05 | 329 | 312 | 17 | GO:0030667 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ABCA2 CEACAM3 CEACAM6 PLD3 SLC15A3 ITGAL WASHC2A ITGAX RHOU SLC39A13 CEACAM1 COLEC12 ADGRE3 VPS13A SEC16A DLG2 NOS3 RAB13 MCOLN2 RAP2A RAP2B WASHC2C ZPLD1 STXBP5 GRIA1 COPG2 APOB SYT2 NCSTN RET SLC2A3 P2RX1 IFT88 SYTL4 CTNS RAP2C PCDH7 SLC26A6 GAA UEVLD | 1.28e-05 | 1307 | 312 | 40 | GO:0030659 |
| GeneOntologyCellularComponent | apical plasma membrane | ERBB3 CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 KL CEACAM21 PSG8 USH2A TEK SLC47A2 CRB1 SLC5A1 VANGL2 SLC7A9 SLC5A11 SYTL4 SLC22A5 PRKG2 SLC26A6 | 1.51e-05 | 487 | 312 | 21 | GO:0016324 |
| GeneOntologyCellularComponent | ciliary membrane | CEACAM5 PSG4 PSG6 PKD1L1 GPR37L1 CEACAM6 CEACAM1 PSG8 TSPEAR | 1.61e-05 | 98 | 312 | 9 | GO:0060170 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LGALS9C LGALS9B MATN1 COL6A5 ERBIN FGL2 COLEC12 FREM2 PTPRZ1 PZP USH2A KNG1 COL5A1 NID2 COL6A2 SEMA3C FRAS1 COL12A1 LGALS9 P3H2 LOX CSTB | 1.71e-05 | 530 | 312 | 22 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | LGALS9C LGALS9B MATN1 COL6A5 ERBIN FGL2 COLEC12 FREM2 PTPRZ1 PZP USH2A KNG1 COL5A1 NID2 COL6A2 SEMA3C FRAS1 COL12A1 TECTB TECTA LGALS9 SNED1 P3H2 LOX CSTB | 1.93e-05 | 656 | 312 | 25 | GO:0031012 |
| GeneOntologyCellularComponent | plasma membrane protein complex | ERBB3 ABCA2 CEACAM5 PSG4 PSG6 CEACAM6 ITGA5 ITGAL ITGAX RYR1 CEACAM1 PTPN6 AHNAK SCN1A DLG2 DLG3 PSG8 STXBP5 ITGA8 GRIA1 NCSTN RET FAF1 CRB1 SACM1L LRP5 HTR3B CACNA2D3 | 2.03e-05 | 785 | 312 | 28 | GO:0098797 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | ERBB3 CEACAM5 PSG4 PSG6 CEACAM6 ITGA5 ITGAL ITGAX CEACAM1 PTPN6 DLG3 PSG8 STXBP5 ITGA8 GRIA1 SACM1L HTR3B | 2.25e-05 | 350 | 312 | 17 | GO:0098802 |
| GeneOntologyCellularComponent | synaptic membrane | ERBB3 DGKB ITGA5 PTPRZ1 SCN1A CNTN5 DLG2 DLG3 KCNT1 RAP2A STXBP5 ITGA8 GRIA1 ADGRL1 LRRC4B NCSTN SLC1A6 SLC1A7 SLC2A3 VANGL2 P2RX1 HTR3B CACNA2D3 | 2.45e-05 | 583 | 312 | 23 | GO:0097060 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ERBB3 CEACAM5 PSG4 PSG6 CEACAM6 ERBIN CEACAM1 SLCO1C1 DLG2 DLG3 PSG8 TEK VANGL2 SLC6A12 SLC22A5 SLC26A6 | 2.76e-05 | 320 | 312 | 16 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | ERBB3 CEACAM5 PSG4 PSG6 CEACAM6 ERBIN CEACAM1 FAP SLCO1C1 DLG2 DLG3 PSG8 TEK VANGL2 SLC6A12 SLC22A5 SLC26A6 | 5.90e-05 | 378 | 312 | 17 | GO:0045178 |
| GeneOntologyCellularComponent | adherens junction | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 DLG2 DLG3 PSG8 DSC2 CRB1 SPTBN4 EIF4G2 | 8.71e-05 | 212 | 312 | 12 | GO:0005912 |
| GeneOntologyCellularComponent | basal plasma membrane | ERBB3 CEACAM5 PSG4 PSG6 CEACAM6 ERBIN CEACAM1 SLCO1C1 DLG2 DLG3 PSG8 TEK VANGL2 SLC6A12 SLC22A5 SLC26A6 | 9.17e-05 | 354 | 312 | 16 | GO:0009925 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | TMPRSS15 PCDH15 USH2A TSPEAR PKHD1L1 SLC5A1 SLC7A9 IFT88 SLC22A5 SLC28A2 CEACAM16 SLC26A6 | 1.40e-04 | 223 | 312 | 12 | GO:0098862 |
| GeneOntologyCellularComponent | tertiary granule | 1.84e-04 | 164 | 312 | 10 | GO:0070820 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 6.02e-04 | 157 | 312 | 9 | GO:0098839 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 7.75e-04 | 73 | 312 | 6 | GO:0070821 | |
| GeneOntologyCellularComponent | protein kinase complex | 1.06e-03 | 170 | 312 | 9 | GO:1902911 | |
| GeneOntologyCellularComponent | stereocilium bundle | 1.17e-03 | 79 | 312 | 6 | GO:0032421 | |
| GeneOntologyCellularComponent | postsynaptic membrane | ERBB3 DGKB ITGA5 PTPRZ1 DLG2 DLG3 KCNT1 ITGA8 GRIA1 LRRC4B SLC1A6 SLC1A7 VANGL2 P2RX1 HTR3B | 1.20e-03 | 405 | 312 | 15 | GO:0045211 |
| GeneOntologyCellularComponent | integrin complex | 1.26e-03 | 32 | 312 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | ATF4-CREB1 transcription factor complex | 1.31e-03 | 4 | 312 | 2 | GO:1990589 | |
| GeneOntologyCellularComponent | secretory granule | IMPDH1 CEACAM3 CEACAM6 ITGAL ITGAX CEACAM1 FGL2 PTPN6 ADGRE3 VPS13A EXOC3L1 RAB13 KNG1 RAP2B TCN1 STXBP5 NPC2 SYT2 NCSTN SLC2A3 P2RX1 IFT88 SYTL4 GUSB CSTB RAP2C PCDH7 GAA | 1.35e-03 | 1014 | 312 | 28 | GO:0030141 |
| GeneOntologyCellularComponent | collagen trimer | 2.05e-03 | 88 | 312 | 6 | GO:0005581 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 2.16e-03 | 5 | 312 | 2 | GO:0070418 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 2.28e-03 | 18 | 312 | 3 | GO:0120212 | |
| GeneOntologyCellularComponent | basement membrane | 2.39e-03 | 122 | 312 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | specific granule membrane | 2.43e-03 | 91 | 312 | 6 | GO:0035579 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.52e-03 | 157 | 312 | 8 | GO:1902554 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SPTB DGKB PLXND1 ITGA5 ERBIN PTPRZ1 DLG2 DLG3 CPSF2 CPEB3 ITGA8 GRIA1 ADGRL1 LRRC4B SLC1A6 SLC1A7 SLC2A3 ARF1 ARF4 SACM1L VANGL2 P2RX1 CPNE4 | 2.82e-03 | 817 | 312 | 23 | GO:0098978 |
| GeneOntologyCellularComponent | specific granule | 2.84e-03 | 160 | 312 | 8 | GO:0042581 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.86e-03 | 94 | 312 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | presynaptic membrane | SCN1A CNTN5 STXBP5 GRIA1 ADGRL1 LRRC4B NCSTN SLC1A6 SLC1A7 P2RX1 CACNA2D3 | 3.12e-03 | 277 | 312 | 11 | GO:0042734 |
| GeneOntologyCellularComponent | membrane protein complex | ERBB3 ABCA2 CEACAM5 PDSS1 PSG4 PSG6 PKD1L1 CEACAM6 ITGA5 ITGAL ITGAX RYR1 MAP3K5 CEACAM1 PTPN6 AHNAK SCN1A AFG3L2 DLG2 DLG3 PSG8 STXBP5 ITGA8 GRIA1 COPG2 NCSTN RET SLC1A6 FAF1 CRB1 SACM1L LRP5 HTR3B SLC26A6 CACNA2D3 UEVLD | 3.22e-03 | 1498 | 312 | 36 | GO:0098796 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.33e-03 | 201 | 312 | 9 | GO:0099634 | |
| GeneOntologyCellularComponent | stereocilium | 3.70e-03 | 69 | 312 | 5 | GO:0032420 | |
| GeneOntologyCellularComponent | secretory vesicle | IMPDH1 CEACAM3 CEACAM6 ITGAL ITGAX SEPTIN6 CEACAM1 FGL2 PTPN6 ADGRE3 VPS13A DLG2 EXOC3L1 RAB13 KNG1 RAP2B TCN1 STXBP5 GRIA1 NPC2 SYT2 NCSTN SLC2A3 P2RX1 IFT88 SYTL4 GUSB CSTB RAP2C PCDH7 GAA | 3.75e-03 | 1246 | 312 | 31 | GO:0099503 |
| GeneOntologyCellularComponent | lamellipodium membrane | 4.11e-03 | 22 | 312 | 3 | GO:0031258 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.06e-08 | 17 | 256 | 7 | MP:0031047 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 5.42e-07 | 28 | 256 | 7 | MP:0020950 | |
| MousePheno | increased skeletal muscle triglyceride level | 1.53e-06 | 21 | 256 | 6 | MP:0031415 | |
| MousePheno | abnormal muscle triglyceride level | 3.37e-06 | 36 | 256 | 7 | MP:0031412 | |
| MousePheno | decreased fatty acid oxidation | 3.63e-06 | 24 | 256 | 6 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 7.62e-06 | 27 | 256 | 6 | MP:0009286 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.37e-05 | 44 | 256 | 7 | MP:0031023 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.78e-05 | 31 | 256 | 6 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 1.78e-05 | 31 | 256 | 6 | MP:0008964 | |
| MousePheno | absent Hensen stripe | 2.40e-05 | 4 | 256 | 3 | MP:0013962 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 2.84e-05 | 49 | 256 | 7 | MP:0020948 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 3.70e-05 | 35 | 256 | 6 | MP:0031618 | |
| MousePheno | abnormal vascular wound healing | 5.45e-05 | 73 | 256 | 8 | MP:0004883 | |
| MousePheno | abnormal Hensen stripe morphology | 5.91e-05 | 5 | 256 | 3 | MP:0013961 | |
| MousePheno | decreased muscle cell glucose uptake | 6.99e-05 | 39 | 256 | 6 | MP:0030022 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.07e-04 | 60 | 256 | 7 | MP:0009790 | |
| MousePheno | abnormal colon morphology | CEACAM5 PSG4 PSG6 NDST4 CEACAM6 CEACAM1 PSG8 FFAR2 RET NR5A2 PRKDC | 1.12e-04 | 152 | 256 | 11 | MP:0000495 |
| MousePheno | increased insulin secretion | 1.62e-04 | 64 | 256 | 7 | MP:0003058 | |
| MousePheno | renal necrosis | 1.94e-04 | 30 | 256 | 5 | MP:0003946 | |
| MousePheno | abnormal tectorial membrane striated-sheet matrix morphology | 2.01e-04 | 7 | 256 | 3 | MP:0014091 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 2.04e-04 | 47 | 256 | 6 | MP:0031617 | |
| MousePheno | enhanced humoral immune response | 2.17e-04 | 17 | 256 | 4 | MP:0020155 | |
| MousePheno | lymph node hyperplasia | 3.09e-04 | 33 | 256 | 5 | MP:0008102 | |
| MousePheno | abnormal tectorial membrane marginal band morphology | 3.34e-04 | 2 | 256 | 2 | MP:0014089 | |
| MousePheno | abnormal CD4-positive, gamma-delta intraepithelial T cell morphology | 3.34e-04 | 2 | 256 | 2 | MP:0008357 | |
| MousePheno | decreased CD4-positive, gamma-delta intraepithelial T cell number | 3.34e-04 | 2 | 256 | 2 | MP:0008359 | |
| Domain | CA | PCDHB5 FREM2 PCDH15 FAT4 DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 RET PCDH20 PCDHGA12 PCDH7 | 5.83e-08 | 115 | 309 | 13 | SM00112 |
| Domain | Cadherin | PCDHB5 FREM2 PCDH15 FAT4 DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 RET PCDH20 PCDHGA12 PCDH7 | 7.95e-08 | 118 | 309 | 13 | IPR002126 |
| Domain | ConA-like_dom | LGALS9C TMPRSS15 BTNL8 LGALS9B RYR1 BTNL3 MID1 USH2A COL5A1 FAT4 COL12A1 FAT3 TSPEAR CRB1 ADGRG6 LGALS9 NEURL4 | 1.51e-07 | 219 | 309 | 17 | IPR013320 |
| Domain | - | CEACAM5 BTNL8 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 PLXND1 DSCAML1 MFAP3L CEACAM1 CEACAM21 BTNL3 PTPRZ1 CNTN5 MID1 PSG8 HCFC2 USH2A IGSF3 SEMA3C COL12A1 DSCAM VSTM2A LRRC4B TEK PKHD1L1 SNED1 EPHA2 CEACAM16 SEMA3E | 2.08e-07 | 663 | 309 | 31 | 2.60.40.10 |
| Domain | Cadherin | PCDHB5 PCDH15 FAT4 DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 RET PCDH20 PCDHGA12 PCDH7 | 3.78e-07 | 113 | 309 | 12 | PF00028 |
| Domain | - | PCDHB5 PCDH15 FAT4 DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 RET PCDH20 PCDHGA12 PCDH7 | 4.17e-07 | 114 | 309 | 12 | 2.60.40.60 |
| Domain | CADHERIN_2 | PCDHB5 PCDH15 FAT4 DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 RET PCDH20 PCDHGA12 PCDH7 | 4.17e-07 | 114 | 309 | 12 | PS50268 |
| Domain | Cadherin-like | PCDHB5 PCDH15 FAT4 DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 RET PCDH20 PCDHGA12 PCDH7 | 5.04e-07 | 116 | 309 | 12 | IPR015919 |
| Domain | Ig-like_fold | CEACAM5 BTNL8 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 PLXND1 DSCAML1 MFAP3L CEACAM1 CEACAM21 BTNL3 PTPRZ1 CNTN5 MID1 PSG8 HCFC2 USH2A IGSF3 SEMA3C COL12A1 DSCAM VSTM2A LRRC4B TEK PKHD1L1 SNED1 EPHA2 CEACAM16 SEMA3E | 8.06e-07 | 706 | 309 | 31 | IPR013783 |
| Domain | Ig_V-set | CEACAM5 BTNL8 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 DSCAML1 CEACAM1 CEACAM21 BTNL3 PSG8 IGSF3 DSCAM VSTM2A | 1.19e-06 | 199 | 309 | 15 | IPR013106 |
| Domain | Cadherin_CS | PCDHB5 PCDH15 FAT4 DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 PCDH20 PCDHGA12 PCDH7 | 1.94e-06 | 109 | 309 | 11 | IPR020894 |
| Domain | CADHERIN_1 | PCDHB5 PCDH15 FAT4 DSC2 PCDHGB7 FAT3 PCDHB14 PCDHB9 PCDH20 PCDHGA12 PCDH7 | 2.77e-06 | 113 | 309 | 11 | PS00232 |
| Domain | Ig_2 | 3.17e-06 | 73 | 309 | 9 | PF13895 | |
| Domain | - | LGALS9C LGALS9B USH2A COL5A1 FAT4 COL12A1 FAT3 CRB1 ADGRG6 LGALS9 | 3.88e-06 | 95 | 309 | 10 | 2.60.120.200 |
| Domain | IG | CEACAM5 BTNL8 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 DSCAML1 MFAP3L CEACAM1 CEACAM21 BTNL3 CNTN5 PSG8 IGSF3 SEMA3C DSCAM VSTM2A LRRC4B CEACAM16 SEMA3E | 7.76e-06 | 421 | 309 | 21 | SM00409 |
| Domain | Ig_sub | CEACAM5 BTNL8 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 DSCAML1 MFAP3L CEACAM1 CEACAM21 BTNL3 CNTN5 PSG8 IGSF3 SEMA3C DSCAM VSTM2A LRRC4B CEACAM16 SEMA3E | 7.76e-06 | 421 | 309 | 21 | IPR003599 |
| Domain | IGc2 | CEACAM5 PSG4 PSG6 PSG7 CEACAM6 DSCAML1 MFAP3L CEACAM1 CEACAM21 CNTN5 PSG8 IGSF3 DSCAM LRRC4B CEACAM16 | 9.22e-06 | 235 | 309 | 15 | SM00408 |
| Domain | Ig_sub2 | CEACAM5 PSG4 PSG6 PSG7 CEACAM6 DSCAML1 MFAP3L CEACAM1 CEACAM21 CNTN5 PSG8 IGSF3 DSCAM LRRC4B CEACAM16 | 9.22e-06 | 235 | 309 | 15 | IPR003598 |
| Domain | V-set | CEACAM5 BTNL8 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 CEACAM1 CEACAM21 BTNL3 PSG8 IGSF3 VSTM2A | 1.24e-05 | 184 | 309 | 13 | PF07686 |
| Domain | Integrin_alpha | 2.21e-05 | 11 | 309 | 4 | PF00357 | |
| Domain | IG_LIKE | CEACAM5 BTNL8 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 DSCAML1 MFAP3L CEACAM1 CEACAM21 BTNL3 CNTN5 PSG8 IGSF3 SEMA3C DSCAM VSTM2A LRRC4B TEK CEACAM16 SEMA3E | 2.50e-05 | 491 | 309 | 22 | PS50835 |
| Domain | Ig-like_dom | CEACAM5 BTNL8 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 DSCAML1 MFAP3L CEACAM1 CEACAM21 BTNL3 CNTN5 PSG8 IGSF3 SEMA3C DSCAM VSTM2A LRRC4B TEK CEACAM16 SEMA3E | 3.60e-05 | 503 | 309 | 22 | IPR007110 |
| Domain | VWA | 3.67e-05 | 56 | 309 | 7 | PF00092 | |
| Domain | NIDO | 4.38e-05 | 5 | 309 | 3 | SM00539 | |
| Domain | NIDO_dom | 4.38e-05 | 5 | 309 | 3 | IPR003886 | |
| Domain | NIDO | 4.38e-05 | 5 | 309 | 3 | PF06119 | |
| Domain | NIDO | 4.38e-05 | 5 | 309 | 3 | PS51220 | |
| Domain | Laminin_G | 4.63e-05 | 58 | 309 | 7 | IPR001791 | |
| Domain | FN3 | KIAA0319L DSCAML1 PTPRZ1 CNTN5 MID1 HCFC2 USH2A COL12A1 DSCAM TEK SNED1 EPHA2 | 6.19e-05 | 185 | 309 | 12 | SM00060 |
| Domain | VWFA | 6.32e-05 | 82 | 309 | 8 | PS50234 | |
| Domain | Small_GTPase | RAB19 RHOU RAB13 RAP2A RAP2B NKIRAS1 ARF1 ARF3 ARF4 ARF5 RAP2C | 7.42e-05 | 160 | 309 | 11 | IPR001806 |
| Domain | VWA | 7.51e-05 | 84 | 309 | 8 | SM00327 | |
| Domain | ig | CEACAM5 PSG4 PSG6 PSG7 CEACAM6 DSCAML1 CEACAM1 CEACAM21 CNTN5 PSG8 DSCAM SEMA3E | 8.01e-05 | 190 | 309 | 12 | PF00047 |
| Domain | Immunoglobulin | CEACAM5 PSG4 PSG6 PSG7 CEACAM6 DSCAML1 CEACAM1 CEACAM21 CNTN5 PSG8 DSCAM SEMA3E | 8.01e-05 | 190 | 309 | 12 | IPR013151 |
| Domain | LamG | 8.12e-05 | 44 | 309 | 6 | SM00282 | |
| Domain | fn3 | DSCAML1 PTPRZ1 CNTN5 MID1 HCFC2 USH2A COL12A1 DSCAM TEK SNED1 EPHA2 | 8.30e-05 | 162 | 309 | 11 | PF00041 |
| Domain | Cadherin_2 | 9.70e-05 | 65 | 309 | 7 | PF08266 | |
| Domain | Cadherin_N | 9.70e-05 | 65 | 309 | 7 | IPR013164 | |
| Domain | Small_GTP-bd_dom | RAB19 RHOU RAB13 RAP2A RAP2B NKIRAS1 ARF1 ARF3 ARF4 ARF5 RAP2C | 1.09e-04 | 167 | 309 | 11 | IPR005225 |
| Domain | Integrin_alpha_C_CS | 1.14e-04 | 16 | 309 | 4 | IPR018184 | |
| Domain | SEMA | 1.43e-04 | 31 | 309 | 5 | PS51004 | |
| Domain | Semap_dom | 1.43e-04 | 31 | 309 | 5 | IPR001627 | |
| Domain | Sema | 1.43e-04 | 31 | 309 | 5 | SM00630 | |
| Domain | Sema | 1.43e-04 | 31 | 309 | 5 | PF01403 | |
| Domain | INTEGRIN_ALPHA | 1.87e-04 | 18 | 309 | 4 | PS00242 | |
| Domain | Integrin_alpha | 1.87e-04 | 18 | 309 | 4 | IPR000413 | |
| Domain | Integrin_alpha-2 | 1.87e-04 | 18 | 309 | 4 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.87e-04 | 18 | 309 | 4 | PF08441 | |
| Domain | FN3_dom | KIAA0319L DSCAML1 PTPRZ1 CNTN5 MID1 HCFC2 USH2A COL12A1 DSCAM TEK SNED1 EPHA2 | 1.97e-04 | 209 | 309 | 12 | IPR003961 |
| Domain | Glycoside_hydrolase_SF | 2.33e-04 | 53 | 309 | 6 | IPR017853 | |
| Domain | Int_alpha | 2.34e-04 | 19 | 309 | 4 | SM00191 | |
| Domain | Int_alpha_beta-p | 2.34e-04 | 19 | 309 | 4 | IPR013519 | |
| Domain | VWF_A | 2.38e-04 | 99 | 309 | 8 | IPR002035 | |
| Domain | FAM21 | 2.73e-04 | 2 | 309 | 2 | IPR027308 | |
| Domain | Semaphorin | 2.89e-04 | 20 | 309 | 4 | IPR027231 | |
| Domain | GPS | 2.97e-04 | 36 | 309 | 5 | PS50221 | |
| Domain | - | RAB19 ABCA2 MFHAS1 NDST4 SLFN5 RHOU SEPTIN6 AFG3L2 DLG2 DLG3 RAB13 RAP2A RAP2B NDST2 CHD8 LRRK1 NKIRAS1 ARF1 ARF3 ARF4 ARF5 RAD50 SBNO1 ABCC12 RAP2C FIGNL1 | 2.98e-04 | 746 | 309 | 26 | 3.40.50.300 |
| Domain | GPS | 3.39e-04 | 37 | 309 | 5 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 3.85e-04 | 38 | 309 | 5 | PS50025 | |
| Domain | FG_GAP | 4.25e-04 | 22 | 309 | 4 | PS51470 | |
| Domain | Quino_amine_DH_bsu | 4.25e-04 | 22 | 309 | 4 | IPR011044 | |
| Domain | - | PPP2R2D EML6 PLXND1 SEMA5B RPTOR PAN2 ANAPC4 SEMA3C STXBP5 SEMA5A NBAS PPP2R2B TBC1D31 STRAP SEMA3E | 4.63e-04 | 333 | 309 | 15 | 2.130.10.10 |
| Domain | Laminin_G_2 | 4.91e-04 | 40 | 309 | 5 | PF02210 | |
| Domain | WD40/YVTN_repeat-like_dom | PPP2R2D EML6 PLXND1 SEMA5B RPTOR PAN2 ANAPC4 SEMA3C STXBP5 SEMA5A NBAS PPP2R2B TBC1D31 STRAP SEMA3E | 4.93e-04 | 335 | 309 | 15 | IPR015943 |
| Domain | FN3 | DSCAML1 PTPRZ1 CNTN5 MID1 HCFC2 USH2A COL12A1 DSCAM TEK SNED1 EPHA2 | 4.97e-04 | 199 | 309 | 11 | PS50853 |
| Domain | EGF | HYAL4 MATN1 ADGRE3 NID2 FAT4 FRAS1 FAT3 TECTA TEK CRB1 SNED1 LRP5 | 5.70e-04 | 235 | 309 | 12 | SM00181 |
| Domain | FG-GAP | 6.01e-04 | 24 | 309 | 4 | PF01839 | |
| Domain | FG-GAP | 6.01e-04 | 24 | 309 | 4 | IPR013517 | |
| Domain | Cadherin_C | 6.18e-04 | 42 | 309 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 6.18e-04 | 42 | 309 | 5 | PF16492 | |
| Domain | NA_SOLUT_SYMP_1 | 6.71e-04 | 11 | 309 | 3 | PS00456 | |
| Domain | Integrin_dom | 7.06e-04 | 25 | 309 | 4 | IPR032695 | |
| Domain | PSI | 7.68e-04 | 44 | 309 | 5 | IPR016201 | |
| Domain | CAP-ZIP_m | 8.10e-04 | 3 | 309 | 2 | PF15255 | |
| Domain | KID | 8.10e-04 | 3 | 309 | 2 | PS50953 | |
| Domain | Polyprenyl_synt_CS | 8.10e-04 | 3 | 309 | 2 | IPR033749 | |
| Domain | FAM21/CAPZIP | 8.10e-04 | 3 | 309 | 2 | IPR029341 | |
| Domain | Coactivator_CBP_pKID | 8.10e-04 | 3 | 309 | 2 | IPR003102 | |
| Domain | pKID | 8.10e-04 | 3 | 309 | 2 | PF02173 | |
| Domain | Na/solute_symporter | 8.83e-04 | 12 | 309 | 3 | IPR001734 | |
| Domain | SSF | 8.83e-04 | 12 | 309 | 3 | PF00474 | |
| Domain | NA_SOLUT_SYMP_2 | 8.83e-04 | 12 | 309 | 3 | PS00457 | |
| Domain | NA_SOLUT_SYMP_3 | 8.83e-04 | 12 | 309 | 3 | PS50283 | |
| Domain | PSI | 9.44e-04 | 46 | 309 | 5 | SM00423 | |
| Domain | EGF-like_dom | MATN1 ADGRE3 NID2 FAT4 FRAS1 FAT3 TECTA TEK ADAM12 CRB1 SNED1 LRP5 | 9.45e-04 | 249 | 309 | 12 | IPR000742 |
| Domain | EGF-like_Ca-bd_dom | 1.07e-03 | 124 | 309 | 8 | IPR001881 | |
| Domain | ARF | 1.26e-03 | 29 | 309 | 4 | PS51417 | |
| Domain | Small_GTPase_ARF | 1.26e-03 | 29 | 309 | 4 | IPR024156 | |
| Domain | Ig_I-set | CEACAM5 CEACAM6 DSCAML1 MFAP3L CEACAM1 CEACAM21 CNTN5 SEMA3C DSCAM LRRC4B | 1.29e-03 | 190 | 309 | 10 | IPR013098 |
| Domain | I-set | CEACAM5 CEACAM6 DSCAML1 MFAP3L CEACAM1 CEACAM21 CNTN5 SEMA3C DSCAM LRRC4B | 1.29e-03 | 190 | 309 | 10 | PF07679 |
| Domain | EGF_CA | 1.29e-03 | 99 | 309 | 7 | PS01187 | |
| Domain | - | 1.41e-03 | 74 | 309 | 6 | 3.40.50.410 | |
| Domain | ZP_2 | 1.43e-03 | 14 | 309 | 3 | PS51034 | |
| Domain | ZP_1 | 1.43e-03 | 14 | 309 | 3 | PS00682 | |
| Domain | DLG1_PEST_dom | 1.60e-03 | 4 | 309 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 1.60e-03 | 4 | 309 | 2 | IPR019583 | |
| Domain | POLYPRENYL_SYNTHASE_1 | 1.60e-03 | 4 | 309 | 2 | PS00723 | |
| Domain | ROC | 1.60e-03 | 4 | 309 | 2 | PS51424 | |
| Domain | Heparan_SO4_deacetylase | 1.60e-03 | 4 | 309 | 2 | IPR021930 | |
| Domain | PP2A_PR55 | 1.60e-03 | 4 | 309 | 2 | IPR000009 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | CEACAM5 PSG4 PSG6 MATN1 CEACAM6 COL6A5 ITGA5 ITGAL ITGAX CEACAM1 PSG8 COL5A1 NID2 COL6A2 COL12A1 ITGA8 ADAM12 P3H2 LOX | 6.45e-08 | 258 | 235 | 19 | MM14572 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | CEACAM5 PSG4 PSG6 PSG7 CEACAM3 CEACAM6 ITGA5 ITGAL ITGAX CEACAM1 PTPN6 PSG8 IGHV1-69 APOB TEK SLC7A9 | 1.57e-07 | 194 | 235 | 16 | M16312 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | CEACAM5 PSG4 PSG6 CEACAM6 ITGA5 ITGAL ITGAX CEACAM1 PTPN6 PSG8 APOB TEK SLC7A9 | 2.41e-06 | 158 | 235 | 13 | MM14812 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SPTB COL6A5 PLXND1 ITGA5 DSCAML1 COL5A1 COL6A2 DSCAM SEMA5A NCSTN RET CREB1 ADGRG6 SPTBN4 EPHA2 SEMA3E | 7.93e-06 | 261 | 235 | 16 | MM15676 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC15A3 SLCO1C1 SLC5A9 SLC1A6 SLC47A2 SLC1A7 SLC2A3 SLC5A1 SLC7A9 SLC5A11 SLC6A12 SLC22A5 SLC28A2 CTNS SLC26A6 | 1.88e-05 | 249 | 235 | 15 | M5988 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.56e-05 | 38 | 235 | 6 | MM14969 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 4.01e-05 | 99 | 235 | 9 | MM14624 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | MATN1 CEACAM6 COL6A5 ITGA5 ITGAL ITGAX CEACAM1 COL5A1 NID2 COL6A2 COL12A1 ITGA8 NCSTN ADAM12 P3H2 LOX | 4.41e-05 | 300 | 235 | 16 | M610 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC15A3 SLCO1C1 SLC5A9 SLC1A6 SLC1A7 SLC2A3 SLC5A1 SLC7A9 SLC5A11 SLC6A12 SLC22A5 SLC28A2 CTNS SLC26A6 | 4.65e-05 | 238 | 235 | 14 | MM15076 |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 PTPN6 PSG8 CREB1 ARF4 ATF1 SMAD2 SMAD3 | 7.47e-05 | 188 | 235 | 12 | MM15828 |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 8.81e-05 | 6 | 235 | 3 | M26970 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.22e-04 | 47 | 235 | 6 | MM14925 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | CEACAM5 IMPDH1 PSG4 PSG6 CEACAM6 ITGAL ITGAX CEACAM1 FGL2 PTPN6 PSG8 RAP2B CLEC6A NPC2 NCSTN SLC2A3 P2RX1 GUSB CSTB RAP2C GAA | 1.32e-04 | 511 | 235 | 21 | MM15330 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.69e-04 | 76 | 235 | 7 | MM14867 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SPTB COL6A5 PLXND1 ITGA5 DSCAML1 COL5A1 COL6A2 DSC2 DSCAM SEMA5A NCSTN XPO1 RET CREB1 ADGRG6 SPTBN4 EPHA2 SMAD2 SMAD3 SEMA3E | 2.88e-04 | 502 | 235 | 20 | MM14537 |
| Pubmed | 1.59e-11 | 14 | 317 | 7 | 9047385 | ||
| Pubmed | 2.96e-11 | 15 | 317 | 7 | 25490771 | ||
| Pubmed | 2.96e-11 | 15 | 317 | 7 | 21029969 | ||
| Pubmed | 5.22e-11 | 16 | 317 | 7 | 9867848 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 5.22e-11 | 16 | 317 | 7 | 11284729 | |
| Pubmed | CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling. | 5.22e-11 | 16 | 317 | 7 | 23696226 | |
| Pubmed | 8.80e-11 | 17 | 317 | 7 | 23734002 | ||
| Pubmed | 8.80e-11 | 17 | 317 | 7 | 16595723 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCA2 B4GALNT1 NAGA KIAA0319L PLXND1 ITGA5 PLD3 ZZEF1 SLC39A13 FAP FBXO22 XPO6 BTD TMCO3 CPSF2 IGSF3 COL5A1 SEMA3C FAT4 FRAS1 COL12A1 HYOU1 NPC2 NCSTN ADAM12 SACM1L STRAP METTL9 P3H2 GUSB LOX EPHA2 CSTB LRP5 PCDH7 SMAD2 LRRFIP1 | 1.25e-10 | 1201 | 317 | 37 | 35696571 |
| Pubmed | 2.24e-10 | 19 | 317 | 7 | 22496641 | ||
| Pubmed | KIAA0319L SRP68 PLXND1 ERBIN AHNAK VPS13A SEC16A DLG3 HCFC2 MGA IGSF3 FAT4 DSC2 DSCAM COPG2 APOB PKHD1L1 ARF1 ARF3 ARF4 CRB1 SLC30A6 ARF5 SF3B1 SYTL4 EPHA2 PRKDC PCDH7 | 8.69e-10 | 777 | 317 | 28 | 35844135 | |
| Pubmed | ABCA2 PPP2R2D SPART PLXND1 ZZEF1 SEMA5B FDPS RPTOR PAN2 CEP126 CPSF2 KCNT1 IGSF3 UFL1 CHD8 SPG11 LRRK1 NCSTN ERI2 VANGL2 KDM4A SEMA3E ZNF646 | 8.80e-10 | 529 | 317 | 23 | 14621295 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 8.89e-10 | 13 | 317 | 6 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 8.89e-10 | 13 | 317 | 6 | 19273835 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 20044046 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 32150576 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 8.89e-10 | 13 | 317 | 6 | 12832451 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 25406283 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 8380065 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 1279194 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 25724769 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 8.89e-10 | 13 | 317 | 6 | 22092845 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 8.89e-10 | 13 | 317 | 6 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 8.89e-10 | 13 | 317 | 6 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 8.89e-10 | 13 | 317 | 6 | 23800882 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 8.89e-10 | 13 | 317 | 6 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 8.89e-10 | 13 | 317 | 6 | 39168268 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 8402684 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 8.89e-10 | 13 | 317 | 6 | 21949477 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 26219866 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 2133556 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 8.89e-10 | 13 | 317 | 6 | 19358828 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 8.89e-10 | 13 | 317 | 6 | 34058224 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 8.89e-10 | 13 | 317 | 6 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 8.89e-10 | 13 | 317 | 6 | 25972571 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 8.89e-10 | 13 | 317 | 6 | 15220458 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 18843289 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 15207636 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 21081647 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 11133662 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 11483763 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 18003729 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 8.89e-10 | 13 | 317 | 6 | 27695943 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 8.89e-10 | 13 | 317 | 6 | 16638824 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 8.89e-10 | 13 | 317 | 6 | 21670291 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 22162753 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 2702644 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 11801635 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 21760897 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 1719235 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 16619040 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 8.89e-10 | 13 | 317 | 6 | 8209741 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 32521208 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 8.89e-10 | 13 | 317 | 6 | 29967450 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 1653760 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 32169849 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 8.89e-10 | 13 | 317 | 6 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 8.89e-10 | 13 | 317 | 6 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 8.89e-10 | 13 | 317 | 6 | 15316023 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 15331748 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 8.89e-10 | 13 | 317 | 6 | 22406619 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 7628460 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 19008452 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 2164599 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 29396368 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 8.89e-10 | 13 | 317 | 6 | 33352461 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 38381498 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 1633107 | ||
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 8.89e-10 | 13 | 317 | 6 | 32027621 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 8.89e-10 | 13 | 317 | 6 | 27777319 | |
| Pubmed | 8.89e-10 | 13 | 317 | 6 | 18848945 | ||
| Pubmed | 1.54e-09 | 14 | 317 | 6 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.54e-09 | 14 | 317 | 6 | 34666041 | |
| Pubmed | 1.54e-09 | 14 | 317 | 6 | 34619794 | ||
| Pubmed | 1.54e-09 | 14 | 317 | 6 | 8896983 | ||
| Pubmed | 1.54e-09 | 14 | 317 | 6 | 22962327 | ||
| Pubmed | 1.54e-09 | 14 | 317 | 6 | 17623671 | ||
| Pubmed | 1.54e-09 | 14 | 317 | 6 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.54e-09 | 14 | 317 | 6 | 18794798 | |
| Pubmed | 1.54e-09 | 14 | 317 | 6 | 23469261 | ||
| Pubmed | 1.54e-09 | 14 | 317 | 6 | 18454175 | ||
| Interaction | C2CD4B interactions | 2.99e-07 | 44 | 308 | 8 | int:C2CD4B | |
| Interaction | CEACAM1 interactions | 5.43e-07 | 21 | 308 | 6 | int:CEACAM1 | |
| Interaction | UCN3 interactions | 9.84e-07 | 23 | 308 | 6 | int:UCN3 | |
| Interaction | FBXO2 interactions | ABCA2 KIAA0319L PLXND1 ITGA5 COLEC12 BTD ADGRF1 IGSF3 NID2 COL6A2 SEMA3C FRAS1 COL12A1 HYOU1 DSC2 ITGA8 NCSTN ADGRG6 SNED1 GUSB GAA | 1.58e-06 | 411 | 308 | 21 | int:FBXO2 |
| Interaction | DKKL1 interactions | 7.93e-06 | 111 | 308 | 10 | int:DKKL1 | |
| Interaction | SH2D2A interactions | 1.35e-05 | 52 | 308 | 7 | int:SH2D2A | |
| Interaction | CEACAM8 interactions | CEACAM6 CEACAM1 FREM2 IGSF3 FAT4 FRAS1 ZPLD1 ITGA8 GUSB CACNA2D3 | 1.47e-05 | 119 | 308 | 10 | int:CEACAM8 |
| Interaction | SKIL interactions | 1.47e-05 | 119 | 308 | 10 | int:SKIL | |
| Interaction | XAGE1A interactions | 3.48e-05 | 41 | 308 | 6 | int:XAGE1A | |
| Interaction | PSG8 interactions | 3.48e-05 | 41 | 308 | 6 | int:PSG8 | |
| Interaction | ADAMTS13 interactions | 4.08e-05 | 26 | 308 | 5 | int:ADAMTS13 | |
| Interaction | CEACAM5 interactions | 4.75e-05 | 14 | 308 | 4 | int:CEACAM5 | |
| Interaction | COPB1 interactions | SLC15A3 ERBIN COPG2 UFL1 TEX15 XPO1 ARF1 ARF3 ARF4 SACM1L ARF5 LGALS9 SF3B1 MEPCE NUDCD1 | 5.08e-05 | 294 | 308 | 15 | int:COPB1 |
| Cytoband | 19q13.2 | 2.36e-06 | 164 | 317 | 9 | 19q13.2 | |
| Cytoband | 7q31.3 | 1.40e-04 | 15 | 317 | 3 | 7q31.3 | |
| Cytoband | 5q31 | 1.55e-04 | 115 | 317 | 6 | 5q31 | |
| GeneFamily | Adenosine receptors|V-set domain containing | CEACAM5 BTNL8 PSG4 PSG6 CEACAM3 CEACAM6 CEACAM1 CEACAM21 BTNL3 PSG8 IGSF3 VSTM2A CEACAM16 | 1.25e-07 | 163 | 224 | 13 | 590 |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 3.78e-07 | 24 | 224 | 6 | 906 | |
| GeneFamily | Solute carriers | SLC15A3 SLC39A13 SLCO1C1 SLC5A9 FLVCR2 SLC1A6 SLC47A2 SLC1A7 SLC2A3 SLC5A1 SLC30A6 SLC7A9 SLC5A11 SLC6A12 SLC22A5 SLC28A2 SLC38A6 SLC26A6 SLC25A45 | 5.16e-07 | 395 | 224 | 19 | 752 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 7.07e-06 | 11 | 224 | 4 | 1315 | |
| GeneFamily | Immunoglobulin like domain containing | CEACAM5 CEACAM6 DSCAML1 CEACAM1 CEACAM21 CNTN5 IGSF3 DSCAM TEK CEACAM16 SEMA3E | 2.98e-05 | 193 | 224 | 11 | 594 |
| GeneFamily | Fibronectin type III domain containing | DSCAML1 PTPRZ1 CNTN5 MID1 USH2A COL12A1 DSCAM TEK SNED1 EPHA2 | 3.14e-05 | 160 | 224 | 10 | 555 |
| GeneFamily | Cadherin related | 4.81e-05 | 17 | 224 | 4 | 24 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 6.12e-05 | 18 | 224 | 4 | 1160 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 9.51e-05 | 20 | 224 | 4 | 736 | |
| GeneFamily | RAS type GTPase family | 5.55e-04 | 31 | 224 | 4 | 389 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 5.55e-04 | 31 | 224 | 4 | 357 | |
| GeneFamily | Galectins | 7.65e-04 | 15 | 224 | 3 | 629 | |
| GeneFamily | Clustered protocadherins | 1.18e-03 | 64 | 224 | 5 | 20 | |
| GeneFamily | WASH complex | 2.22e-03 | 6 | 224 | 2 | 1331 | |
| GeneFamily | Collagens | 2.49e-03 | 46 | 224 | 4 | 490 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.08e-03 | 7 | 224 | 2 | 1113 | |
| GeneFamily | Exportins | 3.08e-03 | 7 | 224 | 2 | 547 | |
| GeneFamily | Schlafen family | 3.08e-03 | 7 | 224 | 2 | 1110 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.98e-03 | 161 | 224 | 7 | 593 | |
| GeneFamily | SMAD family | 4.07e-03 | 8 | 224 | 2 | 750 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.19e-03 | 9 | 224 | 2 | 1234 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | CEACAM5 PSG4 PSG6 CEACAM6 SLC15A3 ITGAX CEACAM1 CEACAM21 A2ML1 PSG8 PZP CLEC6A SLFN12 LALBA SLC30A6 APOL3 | 3.52e-09 | 201 | 317 | 16 | MM1006 |
| Coexpression | NABA_MATRISOME | HYAL4 LGALS9C TMPRSS15 LGALS9B MATN1 COL6A5 PLXND1 FGL2 COLEC12 FREM2 SEMA5B A2ML1 HCFC2 PZP KNG1 COL5A1 NID2 COL6A2 SEMA3C FRAS1 COL12A1 CLEC6A ZPLD1 TECTB TSPEAR SEMA5A TECTA ADAM12 LGALS9 SNED1 P3H2 LOX TNFSF13B CSTB C1QTNF12 SEMA3E | 7.45e-09 | 1008 | 317 | 36 | MM17056 |
| Coexpression | NABA_MATRISOME | HYAL4 LGALS9C TMPRSS15 LGALS9B MATN1 COL6A5 PLXND1 FGL2 COLEC12 FREM2 SEMA5B A2ML1 HCFC2 PZP USH2A KNG1 COL5A1 NID2 COL6A2 SEMA3C FRAS1 COL12A1 CLEC6A ZPLD1 TECTB TSPEAR SEMA5A TECTA ADAM12 LGALS9 SNED1 P3H2 LOX TNFSF13B CSTB SEMA3E | 1.17e-08 | 1026 | 317 | 36 | M5889 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 2.08e-06 | 32 | 317 | 6 | MM2 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.50e-06 | 75 | 317 | 8 | MM605 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 3.61e-06 | 35 | 317 | 6 | MM757 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 COLEC12 PNPT1 AHNAK PSG8 LRRK1 | 3.74e-06 | 128 | 317 | 10 | MM1000 |
| Coexpression | NABA_ECM_AFFILIATED | LGALS9C LGALS9B PLXND1 COLEC12 FREM2 SEMA5B SEMA3C CLEC6A SEMA5A LGALS9 SEMA3E | 3.78e-06 | 158 | 317 | 11 | MM17063 |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP | PSG7 SPART COLEC12 PTPRZ1 KNG1 IGSF3 COL5A1 ADAM12 ARF3 SLC6A12 TBC1D31 SLC22A5 | 4.95e-06 | 195 | 317 | 12 | M8872 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | ERBB3 CEACAM5 PSG4 PSG6 CEACAM6 CEACAM1 PSG8 DSC2 SLC5A9 RHPN2 | 6.03e-06 | 135 | 317 | 10 | MM965 |
| Coexpression | NABA_CORE_MATRISOME | MATN1 COL6A5 FGL2 USH2A COL5A1 NID2 COL6A2 FRAS1 COL12A1 ZPLD1 TECTB TSPEAR TECTA SNED1 | 7.38e-06 | 275 | 317 | 14 | M5884 |
| Coexpression | NABA_ECM_AFFILIATED | LGALS9C LGALS9B PLXND1 COLEC12 FREM2 SEMA5B SEMA3C CLEC6A SEMA5A LGALS9 SEMA3E | 7.64e-06 | 170 | 317 | 11 | M5880 |
| Coexpression | POOLA_INVASIVE_BREAST_CANCER_UP | CEACAM5 CEACAM6 ITGAX ADCY7 FAP COL5A1 NID2 DSC2 IGHV1-69 RET ADAM12 LGALS9 TBC1D31 TOP2A | 1.45e-05 | 292 | 317 | 14 | M5369 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 2.39e-05 | 48 | 317 | 6 | MM531 | |
| Coexpression | NABA_CORE_MATRISOME | MATN1 COL6A5 FGL2 COL5A1 NID2 COL6A2 FRAS1 COL12A1 ZPLD1 TECTB TSPEAR TECTA SNED1 | 2.80e-05 | 270 | 317 | 13 | MM17057 |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN | ERBB3 SPO11 FBXO22 SLFN12 LDHAL6B NPC2 SLC30A6 PKNOX2 NBAS KDM4A UEVLD | 3.03e-05 | 197 | 317 | 11 | M9910 |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | B4GALNT1 MFHAS1 PTPN6 XPO6 ADGRF1 RAP2A RAP2B ARF5 SF3B1 SLC28A2 SLC26A6 | 3.48e-05 | 200 | 317 | 11 | M5059 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | HYAL4 LGALS9C TMPRSS15 LGALS9B PLXND1 COLEC12 FREM2 SEMA5B A2ML1 HCFC2 PZP KNG1 SEMA3C CLEC6A SEMA5A ADAM12 LGALS9 P3H2 LOX TNFSF13B CSTB C1QTNF12 SEMA3E | 3.77e-05 | 738 | 317 | 23 | MM17058 |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 7.05e-05 | 19 | 317 | 4 | M15125 | |
| Coexpression | RAMASWAMY_METASTASIS_DN | 7.85e-05 | 59 | 317 | 6 | M16963 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 9.05e-05 | 87 | 317 | 7 | MM851 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | B4GALNT1 CEACAM5 PSG4 PSG6 CEACAM6 PLD3 ITGAX ADCY7 CEACAM1 IGHV1-69D PSG8 KNG1 DSC2 IGHV1-69 ITGA8 NPC2 CSTB LRRFIP1 | 1.01e-04 | 534 | 317 | 18 | MM1050 |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.24e-04 | 64 | 317 | 6 | M2572 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ERBB3 ITGA5 SSTR1 ERBIN ADCY7 COLEC12 FREM2 KISS1R SEMA5B AHNAK COL5A1 NID2 SEMA3C FAT4 COL12A1 ITGA8 SYT2 LRRK1 FLVCR2 RET ADGRG6 SNED1 LOX EPHA2 LRP5 CORIN TBR1 TOP2A | 1.25e-04 | 1074 | 317 | 28 | M1941 |
| Coexpression | GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL | 1.31e-04 | 41 | 317 | 5 | M39158 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | HYAL4 LGALS9C TMPRSS15 LGALS9B PLXND1 COLEC12 FREM2 SEMA5B A2ML1 HCFC2 PZP KNG1 SEMA3C CLEC6A SEMA5A ADAM12 LGALS9 P3H2 LOX TNFSF13B CSTB SEMA3E | 1.36e-04 | 751 | 317 | 22 | M5885 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.46e-04 | 196 | 317 | 10 | M3008 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN | ACADSB CEACAM1 FBXO22 NID2 RAP2A SLFN12 LDHAL6B GRIA1 SLC6A12 GAA | 1.46e-04 | 196 | 317 | 10 | M4973 |
| Coexpression | GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP | TMPRSS15 ABCA2 RPLP0 MATN1 CREB1 SLC5A11 PPP2R2B PRKG2 TBR1 CACNA2D3 | 1.73e-04 | 200 | 317 | 10 | M9771 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP | 1.73e-04 | 200 | 317 | 10 | M8836 | |
| Coexpression | GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP | 1.73e-04 | 200 | 317 | 10 | M7424 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 1.73e-04 | 200 | 317 | 10 | M7447 | |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP | SLFN5 CNTROB FAP EXOC3L1 MCOLN2 RAP2A CREB1 SLC1A7 ARF1 SMAD2 | 1.73e-04 | 200 | 317 | 10 | M9299 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPR155 TMEM132B DSCAML1 FSIP2 KIAA1549L SCN1A CNTN5 DLG2 DLG3 TMCO3 CEP126 HCFC2 IGSF3 SEMA3C DSCAM STXBP5 VSTM2A CPEB3 APBA2 ITGA8 GRIA1 ADGRL1 LRRC4B CYFIP2 PPP2R2B TNFSF13B PCDH7 SEMA3E | 2.03e-04 | 1106 | 317 | 28 | M39071 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DGKB COL6A5 DSCAML1 KIAA1549L PTPRZ1 USH2A FRAS1 COL12A1 FAT3 TECTB TECTA PKHD1L1 CRB1 ABCC12 CACNA2D3 | 6.43e-13 | 160 | 316 | 15 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DGKB COL6A5 DSCAML1 KIAA1549L PTPRZ1 USH2A FRAS1 COL12A1 FAT3 TECTB TECTA PKHD1L1 CRB1 ABCC12 CACNA2D3 | 6.43e-13 | 160 | 316 | 15 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 DLG2 PZP COL5A1 COL6A2 FAT3 ITGA8 GRIA1 SEMA5A NAALADL2 PKNOX2 SNED1 PCDH7 | 1.05e-11 | 194 | 316 | 15 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 DGKB DSCAML1 FREM2 PCDH15 USH2A FAT4 FRAS1 COL12A1 FOLH1 FAT3 APOB PKHD1L1 | 7.80e-10 | 184 | 316 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 DGKB DSCAML1 FREM2 PCDH15 USH2A FAT4 FRAS1 COL12A1 FOLH1 FAT3 APOB PKHD1L1 | 7.80e-10 | 184 | 316 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMPRSS15 DGKB DSCAML1 FREM2 PCDH15 USH2A FAT4 FRAS1 COL12A1 FOLH1 FAT3 APOB PKHD1L1 | 7.80e-10 | 184 | 316 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 GPR37L1 SSTR1 FSIP2 SEMA5B PTPRZ1 SCN1A PCDH15 SEMA5A TEK SMAD3 SEMA3E | 1.24e-09 | 155 | 316 | 12 | 77fdae85d36efb776db977eb424b32487ef222e4 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 DLG2 COL5A1 COL6A2 FAT3 ITGA8 GRIA1 SEMA5A PKNOX2 SNED1 PCDH7 | 1.49e-09 | 194 | 316 | 13 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | OXGR1 NDST4 FREM2 KIAA1549L PCDH15 USH2A FRAS1 FAT3 TECTA PKHD1L1 SLC7A9 PPP2R2B | 2.06e-09 | 162 | 316 | 12 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OXGR1 NDST4 FREM2 SCN1A PCDH15 ADGRF1 USH2A FRAS1 TECTA CRB1 SLC7A9 | 7.57e-09 | 145 | 316 | 11 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 PZP COL5A1 COL6A2 FAT3 ITGA8 SEMA5A PKNOX2 SNED1 PCDH7 | 1.17e-08 | 189 | 316 | 12 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | GPR155 ERBB3 GPR37L1 SSTR1 TMEM132B DSCAML1 PTPRZ1 PCDH15 DSCAM SEMA5A TEK SEMA3E | 1.25e-08 | 190 | 316 | 12 | 6c7e1086c0a274cd5527c3104106e372811c9905 |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPR37L1 SSTR1 TMEM132B SEMA5B PTPRZ1 PCDH15 DSCAM VSTM2A SEMA5A ADAM12 PCDH20 PRKG2 | 1.32e-08 | 191 | 316 | 12 | ece87127f85939e61b1048d968ed96f0e87c3a79 |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPR37L1 SSTR1 TMEM132B SEMA5B PTPRZ1 PCDH15 DSCAM VSTM2A SEMA5A ADAM12 PCDH20 PRKG2 | 1.32e-08 | 191 | 316 | 12 | 478e8341ee03b05501e2233e02cef5f97492c95d |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | FAP PCDH15 COL5A1 COL6A2 FAT4 FRAS1 FAT3 ITGA8 GRIA1 PKNOX2 SNED1 PCDH7 | 1.48e-08 | 193 | 316 | 12 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 PZP COL5A1 COL6A2 FAT3 ITGA8 SEMA5A PKNOX2 SNED1 PCDH7 | 1.57e-08 | 194 | 316 | 12 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | GPR37L1 TMEM132B SLCO1C1 PTPRZ1 SCN1A PCDH15 DSCAM GRIA1 CRB1 PPP2R2B ZDHHC22 | 3.95e-08 | 170 | 316 | 11 | f78e360a6a44d599ec0d207cba4704e50aa314f8 |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ERBB3 B4GALNT1 ERBIN MFAP3L FGL2 SEMA3C DSC2 EPHA2 SLC28A2 PRKG2 HSD17B11 | 4.73e-08 | 173 | 316 | 11 | e1378201b15ffb98e196ac39fe3ee4b4078953bd |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ERBB3 B4GALNT1 ERBIN MFAP3L FGL2 SEMA3C DSC2 EPHA2 SLC28A2 PRKG2 HSD17B11 | 4.73e-08 | 173 | 316 | 11 | 99532bb768ee35fed939a377acb5215d3f8904bd |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 COL6A2 FAT3 ITGA8 GRIA1 SEMA5A SNED1 LOX PCDH7 | 1.17e-07 | 189 | 316 | 11 | a153b83314cf52808f685296cff8c95af3f4983d |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 MAP3K5 COLEC12 PCDH15 COL6A2 ITGA8 SEMA5A ADAM12 PKNOX2 LOX PCDH7 | 1.23e-07 | 190 | 316 | 11 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 COL6A2 FAT3 ITGA8 SEMA5A PKNOX2 SNED1 LOX PCDH7 | 1.30e-07 | 191 | 316 | 11 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 PZP COL5A1 COL6A2 FAT3 ITGA8 SEMA5A LOX PCDH7 | 1.37e-07 | 192 | 316 | 11 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 COL6A2 FAT3 ITGA8 GRIA1 SEMA5A SNED1 LOX PCDH7 | 1.37e-07 | 192 | 316 | 11 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 PZP COL6A2 FAT3 ITGA8 SEMA5A PKNOX2 SNED1 PCDH7 | 1.37e-07 | 192 | 316 | 11 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 PZP COL6A2 FAT3 ITGA8 SEMA5A PKNOX2 LOX PCDH7 | 1.37e-07 | 192 | 316 | 11 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 COL5A1 COL6A2 FAT3 ITGA8 SEMA5A PKNOX2 LOX PCDH7 | 1.37e-07 | 192 | 316 | 11 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 DLG2 COL5A1 COL6A2 FAT3 ITGA8 SEMA5A SNED1 PCDH7 | 1.44e-07 | 193 | 316 | 11 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COLEC12 FAP PCDH15 COL5A1 FAT4 FAT3 ITGA8 GRIA1 PKNOX2 SNED1 PCDH7 | 1.52e-07 | 194 | 316 | 11 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | ACADSB COLEC12 COL6A2 RAP2A FAT3 ITGA8 GRIA1 RAD50 SNED1 LOX PRKG2 | 1.60e-07 | 195 | 316 | 11 | 3a0cad69cfc150a27a0666f612f5294c817197d7 |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | ACADSB COLEC12 COL6A2 RAP2A FAT3 ITGA8 GRIA1 RAD50 SNED1 LOX PRKG2 | 1.60e-07 | 195 | 316 | 11 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 GPR37L1 SSTR1 TMEM132B PTPRZ1 SCN1A PCDH15 DSCAM SEMA5A TEK SEMA3E | 1.68e-07 | 196 | 316 | 11 | f374cb3ec31c6eef2cef9e07547bfd1e380553af |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 GPR37L1 SSTR1 TMEM132B PTPRZ1 SCN1A PCDH15 DSCAM SEMA5A TEK SEMA3E | 1.68e-07 | 196 | 316 | 11 | 671c380b58d7f634b4fbec38c357d357ea4f3535 |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | COL6A5 FAP MCOLN2 COL5A1 COL6A2 FAT3 ITGA8 GRIA1 ADAM12 PKNOX2 SNED1 | 1.86e-07 | 198 | 316 | 11 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | GPR37L1 SSTR1 SCN1A PCDH15 DSCAM SEMA5A TEK PCDH20 CYFIP2 PRKG2 PCDH7 | 1.96e-07 | 199 | 316 | 11 | 19a97e27a4758e794ce7246d295e112b47931a48 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL6A5 MAP3K5 COLEC12 PCDH15 PZP MCOLN2 CARM1 NID2 COL6A2 SEMA5A PKNOX2 | 1.96e-07 | 199 | 316 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SLC15A3 ITGAX MCOLN2 NDST2 LRRK1 ADAM12 LGALS9 TG VANGL2 SLC6A12 ZNF646 | 1.96e-07 | 199 | 316 | 11 | 82759af613ebfffe037afda55159bf6af812c3ac |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | FAP AHNAK COL5A1 COL6A2 SEMA3C FRAS1 COL12A1 DSC2 SLC47A2 KLHL31 LGALS9 | 2.06e-07 | 200 | 316 | 11 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | FAP AHNAK COL5A1 COL6A2 SEMA3C FRAS1 COL12A1 DSC2 SLC47A2 KLHL31 LGALS9 | 2.06e-07 | 200 | 316 | 11 | ff0b2675c68e9fc1fa16b3276431f199f3642eac |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | COL6A5 COLEC12 FAP PCDH15 PZP MCOLN2 COL5A1 COL6A2 ITGA8 TEX15 SYTL4 | 2.06e-07 | 200 | 316 | 11 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | NDST4 DGKB TMEM132B RYR1 CNTN5 PCDH15 USH2A DSCAM FAT3 CPNE4 | 2.15e-07 | 159 | 316 | 10 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TMPRSS15 B4GALNT1 COL6A5 COLEC12 PCDH15 MCOLN2 FAT3 ABCC12 PCDH7 | 2.78e-07 | 125 | 316 | 9 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | GPR155 ERBB3 SLC15A3 TMEM132B PTPRZ1 AHNAK SEMA3C FAM135B ADGRG6 PPP2R2B | 3.58e-07 | 168 | 316 | 10 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | GPR155 ERBB3 SLC15A3 TMEM132B PTPRZ1 AHNAK SEMA3C FAM135B ADGRG6 PPP2R2B | 3.58e-07 | 168 | 316 | 10 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | FAP SLCO1C1 PTPRZ1 COL5A1 SEMA3C FAT4 COL12A1 PKNOX2 CORIN PCDH7 | 5.49e-07 | 176 | 316 | 10 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | FAP SLCO1C1 PTPRZ1 COL5A1 SEMA3C FAT4 COL12A1 PKNOX2 CORIN PCDH7 | 5.49e-07 | 176 | 316 | 10 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 DLG2 MCOLN2 FOLH1 FAT3 SNED1 PCDH7 SMAD3 | 6.75e-07 | 180 | 316 | 10 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 PCDH15 DLG2 MCOLN2 FAT3 SNED1 LOX PCDH7 SMAD3 | 6.75e-07 | 180 | 316 | 10 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL6A5 TMEM132B FAP COL5A1 NID2 COL6A2 COL12A1 PCDHGB7 FAT3 ADAM12 | 7.10e-07 | 181 | 316 | 10 | c62b0a2422377ffadaab63edd538e87a06fa5017 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL6A5 TMEM132B FAP COL5A1 NID2 COL6A2 COL12A1 PCDHGB7 FAT3 ADAM12 | 7.10e-07 | 181 | 316 | 10 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | DSCAML1 CNTN5 PCDH15 DLG2 USH2A FAT3 SEMA5A SLC5A1 SLC5A11 CPNE4 | 7.10e-07 | 181 | 316 | 10 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ERBB3 DGKB SLC15A3 TMEM132B PTPRZ1 SCN1A FRAS1 ADAM12 CRB1 PPP2R2B | 7.47e-07 | 182 | 316 | 10 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | ERBB3 SLC15A3 TMEM132B PTPRZ1 SCN1A RET ADAM12 CRB1 ADGRG6 ZDHHC22 | 7.85e-07 | 183 | 316 | 10 | f517215ff45dec914af52dfdbc4579c19654c3aa |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPR37L1 SSTR1 SEMA5B PTPRZ1 PCDH15 DSCAM PCDHB9 SEMA5A PCDH20 PRKG2 | 8.25e-07 | 184 | 316 | 10 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ERBB3 SLC15A3 PTPRZ1 SCN1A DLG2 PCBP4 LDHAL6B RET ADAM12 CRB1 | 8.25e-07 | 184 | 316 | 10 | 7aa245b73e10fd73d292e822de6b72920aa12355 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPR37L1 SSTR1 SEMA5B PTPRZ1 PCDH15 DSCAM PCDHB9 SEMA5A PCDH20 PRKG2 | 8.25e-07 | 184 | 316 | 10 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IMPDH1 SLFN5 CEACAM1 MRTFB SLCO1C1 AHNAK NOS3 SEMA3C TEK LGALS9 | 9.11e-07 | 186 | 316 | 10 | ba6ba75218efc26371cea24ddbb0e9b3e3f421ac |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IMPDH1 SLFN5 CEACAM1 MRTFB SLCO1C1 AHNAK NOS3 SEMA3C TEK LGALS9 | 9.11e-07 | 186 | 316 | 10 | 65e25a9dcef5fc71510aaf170e220deef5b2feb2 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IMPDH1 SLFN5 CEACAM1 MRTFB SLCO1C1 AHNAK NOS3 SEMA3C TEK LGALS9 | 9.11e-07 | 186 | 316 | 10 | e4f1259725160719e5fd13d76e5a707efed70013 |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ERBB3 SLC15A3 PTPRZ1 SCN1A DLG2 PCBP4 ADAM12 CYFIP2 CRB1 ADGRG6 | 9.11e-07 | 186 | 316 | 10 | 76535681667c8afb884fa72b6edfee9e1e46335b |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CEACAM3 ITGAX FGL2 PTPN6 ADGRE3 MCOLN2 CLEC6A NPC2 TNFSF13B CACNA2D3 | 1.00e-06 | 188 | 316 | 10 | c7c2cf1aa328e735073d6031e44b5dbd55beae6d |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPR37L1 SSTR1 SEMA5B PTPRZ1 PCDH15 DSCAM PCDHB9 SEMA5A ADAM12 PCDH7 | 1.00e-06 | 188 | 316 | 10 | a244fcd092d5bd544e503366b1439b0fbc1ee00e |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPR37L1 SSTR1 SEMA5B PTPRZ1 PCDH15 DSCAM PCDHB9 SEMA5A ADAM12 PCDH7 | 1.00e-06 | 188 | 316 | 10 | c8530c9ff98666c64a94683261af4288cb790a7e |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | ITGAL FGL2 XPO6 FFAR2 CYFIP2 SNED1 P2RX1 TNFSF13B SMAD3 RGL4 | 1.05e-06 | 189 | 316 | 10 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPR37L1 SSTR1 TMEM132B SEMA5B PTPRZ1 PCDH15 DSCAM VSTM2A SEMA5A ADAM12 | 1.10e-06 | 190 | 316 | 10 | 9b825b2586c7b173ff27fcf2abc5860faf50984a |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GPR37L1 SSTR1 TMEM132B SEMA5B PTPRZ1 PCDH15 DSCAM VSTM2A SEMA5A ADAM12 | 1.10e-06 | 190 | 316 | 10 | d146af1926474328a7c822bc140c4dda66e1bbfb |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-06 | 148 | 316 | 9 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FAP COL5A1 NID2 COL6A2 SEMA3C COL12A1 FAT3 ITGA8 ADAM12 PCDH7 | 1.16e-06 | 191 | 316 | 10 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | B4GALNT1 ERBIN MFAP3L CEACAM1 ZBTB7A PRRC2C RAP2A DSC2 APOB PHF3 | 1.16e-06 | 191 | 316 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FAP COL5A1 NID2 COL6A2 SEMA3C COL12A1 FAT3 ITGA8 ADAM12 PCDH7 | 1.16e-06 | 191 | 316 | 10 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL6A5 COLEC12 MID1 PCDH15 PZP COL6A2 ITGA8 SEMA5A PKNOX2 PCDH7 | 1.21e-06 | 192 | 316 | 10 | df1545670370fb1010c567cd059c2783eab315f7 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | COLEC12 FAP COL5A1 NID2 COL6A2 RAP2B ITGA8 GRIA1 TEX15 PCDH7 | 1.33e-06 | 194 | 316 | 10 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PLXND1 ITGA5 CEACAM1 SEMA5B NOS3 ITGA8 TEK SNED1 NR5A2 APOL3 | 1.33e-06 | 194 | 316 | 10 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | SLFN5 ITGAL ERBIN AHNAK COL6A2 RAP2A ADGRL1 ADAM12 CYFIP2 PPP2R2B | 1.40e-06 | 195 | 316 | 10 | 9990440bda7fac5d00ef80444fab07459be625e1 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | COL6A5 FAP PCDH15 MCOLN2 COL5A1 COL6A2 FAT3 ITGA8 GRIA1 PKNOX2 | 1.40e-06 | 195 | 316 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FAM185A LGALS9B CEACAM6 FER1L6 FREM2 PTPRZ1 ADGRF1 SEMA3C GSDMC PCDH7 | 1.46e-06 | 196 | 316 | 10 | b07db4a53ab9be9aad6fae5e45f9547db829d096 |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | SLFN5 ITGAL ERBIN AHNAK COL6A2 RAP2A ADGRL1 ADAM12 CYFIP2 PPP2R2B | 1.46e-06 | 196 | 316 | 10 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SLFN5 ITGAL ERBIN AHNAK COL6A2 RAP2A ADGRL1 ADAM12 CYFIP2 PPP2R2B | 1.46e-06 | 196 | 316 | 10 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | DGKB COLEC12 FAP COL6A2 SEMA3C SEMA5A LRRC4B SNED1 PCDH7 SEMA3E | 1.46e-06 | 196 | 316 | 10 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | COLEC12 FAP COL5A1 NID2 COL6A2 FAT4 COL12A1 SEMA5A LRRC4B LOX | 1.46e-06 | 196 | 316 | 10 | 7e178c76285e61c721c38d7a995ebf89dc428f9f |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | DGKB COLEC12 FAP COL6A2 SEMA3C SEMA5A LRRC4B SNED1 PCDH7 SEMA3E | 1.46e-06 | 196 | 316 | 10 | ee45e4de9d706ec87094e87f47d3e514539b8092 |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | SLFN5 ITGAL ERBIN AHNAK COL6A2 RAP2A ADGRL1 ADAM12 CYFIP2 PPP2R2B | 1.46e-06 | 196 | 316 | 10 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | SLFN5 ITGAL ERBIN AHNAK COL6A2 RAP2A ADGRL1 ADAM12 CYFIP2 PPP2R2B | 1.46e-06 | 196 | 316 | 10 | c35f2349dfe35baa845f790b9f31673dceac54c0 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | FAP DLG2 COL5A1 COL6A2 COL12A1 ITGA8 ADAM12 PKNOX2 SNED1 PCDH7 | 1.53e-06 | 197 | 316 | 10 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-06 | 198 | 316 | 10 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ERBB3 SLC15A3 PTPRZ1 SCN1A DLG2 PCBP4 RET ADAM12 CRB1 ADGRG6 | 1.60e-06 | 198 | 316 | 10 | c8272ac4d90f2367f538f66db40de911ad73ea7f |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | RPLP0 COLEC12 AHNAK COL5A1 NID2 COL6A2 COL12A1 SEMA5A ADAM12 SLC2A3 | 1.60e-06 | 198 | 316 | 10 | d9ffc6589ed510ffa60c591f2a0fe123210f1455 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ERBB3 GPR37L1 TMEM132B PTPRZ1 SCN1A PCDH15 DSCAM SEMA5A PCDH7 SEMA3E | 1.60e-06 | 198 | 316 | 10 | 02d0d8a212e09c0962ab1dae6a885d26d357f66a |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL6A5 COLEC12 PZP MCOLN2 COL5A1 NID2 COL6A2 ITGA8 SEMA5A SYTL4 | 1.68e-06 | 199 | 316 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | GPR37L1 SSTR1 SCN1A PCDH15 DSCAM SEMA5A TEK PCDH20 CYFIP2 PCDH7 | 1.68e-06 | 199 | 316 | 10 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | BTNL8 PLXND1 CEACAM1 FGL2 EXOC3L1 ITGA8 TEK PKHD1L1 SLC2A3 APOL3 | 1.68e-06 | 199 | 316 | 10 | fffd2f9042b55531dac4e5b463b5cee80402e7bb |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | GPR37L1 SSTR1 SCN1A PCDH15 DSCAM SEMA5A TEK PCDH20 CYFIP2 PCDH7 | 1.68e-06 | 199 | 316 | 10 | 333056c2abe9724efeab542c0365fcfe4eff8f18 |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | LGALS9C CEACAM5 BTNL8 LGALS9B CEACAM3 CEACAM6 CEACAM1 BTNL3 P3H2 PRKG2 | 1.68e-06 | 199 | 316 | 10 | 01d101b0fd5326947a9e5dddae6c2f93ab6e0a4d |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ERBB3 SLC15A3 PTPRZ1 SCN1A DLG2 PCBP4 RET ADAM12 CRB1 ADGRG6 | 1.68e-06 | 199 | 316 | 10 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COLEC12 FAP COL5A1 COL6A2 SEMA3C COL12A1 SEMA5A LRRC4B SNED1 SEMA3E | 1.76e-06 | 200 | 316 | 10 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PCDH15 MCOLN2 COL5A1 COL6A2 FRAS1 FAT3 ITGA8 GRIA1 PKNOX2 PCDH7 | 1.76e-06 | 200 | 316 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PCDH15 MCOLN2 COL5A1 COL6A2 FRAS1 FAT3 ITGA8 GRIA1 PKNOX2 PCDH7 | 1.76e-06 | 200 | 316 | 10 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COLEC12 FAP COL5A1 COL6A2 SEMA3C COL12A1 SEMA5A LRRC4B SNED1 SEMA3E | 1.76e-06 | 200 | 316 | 10 | de1d193f773f4e2927baa6fc38d29754b015c6e6 |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | DOCK11 SEMA5B PTPRZ1 IGSF3 SEMA3C VSTM2A SEMA5A TECTA PCDH20 | 2.58e-06 | 163 | 316 | 9 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.95e-06 | 124 | 316 | 8 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| Drug | AC1L1IPV | 1.06e-07 | 43 | 311 | 8 | CID000004683 | |
| Drug | Mas-G | 1.16e-06 | 7 | 311 | 4 | CID000195918 | |
| Drug | Indium | 1.34e-06 | 59 | 311 | 8 | CID000105148 | |
| Drug | Rodorubicine | 2.52e-06 | 3 | 311 | 3 | CID000057097 | |
| Drug | type-IV | HYAL4 B4GALNT1 CEACAM5 NAGA CEACAM3 SLC15A3 CEACAM21 TCN1 LALBA ADGRL1 APOB LGALS9 TG GUSB CTNS | 8.29e-06 | 281 | 311 | 15 | CID000000906 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYQGVVQFAVSLVDA | 211 | Q9ULK5 | |
| TLIYIQLSTSFQNAG | 41 | Q0VG73 | |
| QTLIDGQQFLEAYVS | 151 | Q86VI1 | |
| LNTSTGQIDSEFQAY | 66 | A8K979 | |
| LSVTGDAENQYQTLY | 36 | P21860 | |
| GIFISGQQNYSSATL | 1226 | Q96RT1 | |
| IIAVAATNNLYIFQD | 426 | Q00005 | |
| GTISFFNTNDQSLIY | 416 | Q6UXE8 | |
| GKTIQSIAFLQEVYN | 841 | Q9HCK8 | |
| NGASEVSYFQLETNL | 226 | Q9UJX5 | |
| LALLNNVSYNVVEFS | 266 | Q9P2I0 | |
| SLQAASGQEVYQVNL | 166 | Q00973 | |
| SGQEVYQVNLTASLG | 171 | Q00973 | |
| GTISFFNINDQSLIY | 416 | Q6UX41 | |
| RKVTQSAYAQIVQFG | 651 | Q9Y4W6 | |
| ISTVIQNYSINEVFL | 506 | Q5T601 | |
| YSILQSSAGGFAQIQ | 216 | O95264 | |
| VSVVLASRNNNEVYG | 986 | Q86SQ4 | |
| YNNLGLFLSTENATV | 731 | O94910 | |
| YFQNTQGLIFVVDSN | 81 | P84085 | |
| YILQTFNRQLQTEVG | 106 | Q2WEN9 | |
| NVTLEDTGYYNLQVT | 111 | Q3KPI0 | |
| SLLIQNIIQNDTGFY | 106 | P06731 | |
| NNTVLYDSSSVNILG | 166 | Q9BYG8 | |
| FATVNIQLKGTNEYV | 3281 | Q6V0I7 | |
| VFLVIYGTNGTFNQT | 376 | A8K2U0 | |
| VSFKSQVVAGTNYFI | 41 | P04080 | |
| VIAVAATNNLYIFQD | 436 | Q66LE6 | |
| TIYEGASNIQLNTIA | 411 | P45954 | |
| YFDNLQSGEVTQLLN | 61 | Q09666 | |
| DNAQLVSGVYFQGTT | 301 | O43184 | |
| LQSYVLVDQGSQNGT | 466 | Q8N302 | |
| YFQNTQGLIFVVDSN | 81 | P61204 | |
| LLQLQAGQYASVFVD | 266 | Q5T7M4 | |
| NKTQIFNVYGITEVS | 336 | Q4L235 | |
| LIAQSIGQAFSVAYQ | 511 | Q99767 | |
| QNVSILYADIVGFTQ | 276 | P51828 | |
| QVNFVSYVQLTSRAL | 136 | Q7Z5J1 | |
| ILVNNAGVVYTSDLF | 116 | Q8NBQ5 | |
| GTSAELQNNFIEYIS | 136 | Q8N5S3 | |
| FQILEDGSVYTTNTI | 71 | Q02487 | |
| QYFGLQTTSTCIINI | 331 | Q02487 | |
| YSLATGVIASLQQQV | 436 | Q2M243 | |
| FISQETGNLYISKVQ | 246 | O94779 | |
| DNFNNTYISTIGIDF | 31 | P51153 | |
| VYTETQQNTIGVDFT | 41 | A4D1S5 | |
| VLIYVEQVTNQTLSF | 1421 | P20742 | |
| QGFILVYSLVNQQSF | 76 | P10114 | |
| QGFILVYSLVNQQSF | 76 | P61225 | |
| QGFILVYSLVNQQSF | 76 | Q9Y3L5 | |
| IAQDFDIGSNTVQNY | 156 | Q9Y5E4 | |
| GATAVYSQFITQLTD | 661 | Q92878 | |
| QLQGFTYTATAIQNV | 221 | P20702 | |
| QITYSLAENTIQGAS | 486 | O60330 | |
| VVQYALANLTGTVVN | 566 | Q92542 | |
| THVVNLGSNQYLFSV | 431 | Q96RS6 | |
| VFSLDYTTGNILTQQ | 291 | Q9Y5F8 | |
| TLSLFYGVNVENRSQ | 351 | Q86VD1 | |
| KGQSYSVNVTFTSNI | 51 | P61916 | |
| GASNYLQQVVSTFSD | 231 | Q8NEZ5 | |
| TQEQVVDYLTQYSGI | 1031 | Q504Q3 | |
| VLLSANQGFSVQGQY | 191 | P57723 | |
| TDSQINVTVYGNATV | 321 | Q8N6Y1 | |
| NYFTETAGTSLLVTQ | 436 | Q8IV08 | |
| NYAENILTLAGSQQT | 81 | Q6PIW4 | |
| GTISAQDLVNYVQSV | 261 | Q9H511 | |
| VASNIYGTVNNTVTL | 126 | O75121 | |
| IVQYLNTTEQVRSGN | 146 | O15552 | |
| VLVQGSTFTYQDILA | 2021 | Q86XX4 | |
| VSVTVQRTGNLNQYA | 2571 | Q86XX4 | |
| VGIFKNNTALVSQFY | 601 | Q9Y5Z7 | |
| VAAATGTYSQVQLVQ | 11 | A0A0B4J1V7 | |
| LAQVGLVQYSSSVRQ | 311 | P21941 | |
| TSVFPNNVVFVTGNY | 546 | Q7L2J0 | |
| TEFFAVTAYQNIQIT | 231 | Q8IWI9 | |
| AGQSFVAEQLQIEYS | 871 | Q9Y4C4 | |
| TGFTQQTEEQYFQFL | 961 | Q38SD2 | |
| AYAIQNVSFDISIVS | 376 | Q7Z3F1 | |
| TANYAQKFQGRVTIT | 76 | P01742 | |
| YQLTVTDTIGQQATA | 571 | Q8IZA0 | |
| FLQSSYQTEIGQTLD | 226 | P14324 | |
| SVSINNSSLEGFTIY | 531 | Q8NCI6 | |
| VDTISVNGSVQLSYI | 131 | Q6DKI2 | |
| NSLIVGYVIGTQQAT | 76 | P40199 | |
| SLLIQNVTQNDTGFY | 106 | P40199 | |
| NVTQNDTGFYTLQVI | 111 | P40199 | |
| GFVLVYSVNNLESFQ | 81 | Q9NYS0 | |
| VDTISVNGSVQLSYI | 131 | Q3B8N2 | |
| VDTISVNGSVQLSYI | 131 | O00182 | |
| YGILLNNVFDTQVAD | 171 | Q8NHP7 | |
| GTVVYQGTTANILQE | 916 | P98073 | |
| KASTNQGAIDVYVSQ | 286 | Q8N0U4 | |
| SFTVAELAAGQVVYQ | 506 | Q5SZK8 | |
| QIYVAAFTVQAAAET | 731 | Q04609 | |
| YLNQTGAAVQNVVIS | 91 | O75197 | |
| VSAETAGNGLYNFIV | 786 | Q5JUK3 | |
| IVSSSSLQQYVAQGG | 211 | Q8NDZ0 | |
| AIFYSISLTQQGLQG | 286 | O95822 | |
| QSYDISIVAQVDQTG | 446 | Q86X55 | |
| SASVVYQADVQDNGI | 381 | Q5CZC0 | |
| VVDSVYSNILQQSGT | 6421 | Q5CZC0 | |
| VASVNNYTAVFLGTV | 476 | Q9Y4D7 | |
| DYFVTANSNLVIITA | 131 | Q9BYZ2 | |
| NNNIFSIENDTGTIY | 681 | O60245 | |
| GYVTNLQQDTSVLQG | 176 | Q5KU26 | |
| GQAEQQSVVSQFYVS | 676 | Q9ULH7 | |
| GEGLNVIQQTTRYFS | 271 | Q9H9S0 | |
| IRATGFYQNNTLNTA | 91 | H3BRN8 | |
| VTNFYIANLAATDVT | 76 | Q969F8 | |
| IQQLVTGQSGLFTQY | 71 | O75164 | |
| VENNESTEYGLFQIS | 61 | P00709 | |
| ESLQAVFVQSYLDQG | 66 | Q9H1A3 | |
| VFVQSYLDQGTQIFL | 71 | Q9H1A3 | |
| YLDQGTQIFLNNSIE | 76 | Q9H1A3 | |
| NVSLGNVLAVAYATQ | 406 | Q9NY33 | |
| AGYFQLKTVLQFVSQ | 936 | Q6ZVL6 | |
| SQAVTLVYVVGNQST | 996 | Q6ZVL6 | |
| LVYVVGNQSTFLNGT | 1001 | Q6ZVL6 | |
| FASLVSQDYVNGTDQ | 56 | Q9H204 | |
| TYFATSQLLIIDGQQ | 756 | Q9H3R1 | |
| SEEYGNFLVTQKSVQ | 1846 | P23471 | |
| TFVYNSEQLNGTQRV | 451 | Q8IVL5 | |
| RNTIYAALQDFAQVT | 476 | Q96F07 | |
| GLVIQQVFDNGSIYN | 186 | P05388 | |
| TVTVDNGNIYVTLSN | 121 | Q8TAC1 | |
| TANYAQKFQGRVTIT | 76 | A0A0B4J2H0 | |
| VVTEYLNSGNANEAV | 551 | P78344 | |
| LAFQTDGFLQVQYAI | 126 | P0C7M6 | |
| TYAQESNVQALEILF | 731 | A2RRP1 | |
| GQVITASVADIIANY | 226 | P53708 | |
| GAQNFGYVSIINSTD | 291 | P53708 | |
| TFNQTVGTFEELQKY | 386 | Q13237 | |
| IVLDSSQGNSVYQIA | 271 | P20839 | |
| VGSITYDTLSAQAQQ | 76 | P29474 | |
| FGNLLLYVVVSDNFQ | 296 | Q96P68 | |
| IGSNTEVFTYNAANK | 471 | Q14112 | |
| GQILSATQEQIAESY | 231 | P08648 | |
| GVISAAAINQSIVYS | 1056 | Q96QU1 | |
| AAINQSIVYSIVSGN | 1061 | Q96QU1 | |
| VIQSYTINIQATDGG | 311 | Q9Y5E9 | |
| DTFINNVVIYFATGV | 191 | O76099 | |
| AAVLSAQVYSAVLQG | 11 | Q8IZJ4 | |
| LYQELLTQEGQASFQ | 4151 | P04114 | |
| QLINDNTATALSYGV | 201 | Q9Y4L1 | |
| YRLFIQNVAVQDSGT | 901 | O75054 | |
| QNIGVTFIQAGQYSD | 276 | Q13099 | |
| LNNVTGIVQVYNTDT | 571 | Q53HC5 | |
| YNNLANAVISVSGIN | 351 | P15169 | |
| SQLRYIQQGIFSVTN | 456 | Q5JSL3 | |
| NNYELDFGQIITISI | 396 | O00341 | |
| QQSYIAAISARFVQL | 601 | Q8NE35 | |
| AYNLTEKNFASVQGV | 2526 | Q99715 | |
| GQEALTTIYNTILTQ | 2596 | Q9UFH2 | |
| SYPFNNGDLTISINV | 4051 | Q9UFH2 | |
| NNGFILVSEDYTQTG | 861 | Q8IZS8 | |
| EGTFSSVYLATAQLQ | 66 | O00311 | |
| SLLIQNVTQNDTGFY | 106 | P13688 | |
| NVTQNDTGFYTLQVI | 111 | P13688 | |
| YVLQSDGVQQTTYLA | 366 | Q5T2R2 | |
| VGTSLYFVNDSLQQV | 21 | Q8TD84 | |
| YSEQINNFGQSVLLS | 981 | Q9P2H0 | |
| QLNSTVVGLTVVYAF | 356 | O60883 | |
| TTYLVQVQALTQEGQ | 501 | P29317 | |
| NSLSVRLGSYVQNIF | 166 | P82251 | |
| SVEQDSGLVNYQISV | 236 | P08236 | |
| VTIFSVGVYNANRSQ | 756 | A8TX70 | |
| NIYESAANTLGIFNS | 6 | Q96A23 | |
| IGYTNFTLEKNFVIN | 626 | P12110 | |
| QFAINSSTGIVYVAD | 876 | Q8TDW7 | |
| TLVNVLYVTQQFAGE | 116 | Q53R41 | |
| INYINVGEIASFISS | 531 | Q53R41 | |
| QFVSSDLGSYIANVT | 356 | Q2M3T9 | |
| NQDTVIDLGISFQIY | 496 | Q13617 | |
| SIINNYFSIGVDASI | 581 | Q9Y6T7 | |
| YRFVQNVTSDLQLAA | 266 | P85037 | |
| EFGFLQYANSTVTQL | 81 | Q9BZC7 | |
| AYQDNVTVFASVIFQ | 596 | Q9BZC7 | |
| TNVVFSNNGTLVDRY | 196 | P43251 | |
| LNNYYEATQTIGSEI | 281 | O95236 | |
| YFQNTQGLIFVVDSN | 81 | P84077 | |
| NSLIVGYVIGTQQAT | 76 | P40198 | |
| SLLIQNVTQNDIGFY | 106 | P40198 | |
| NVTQNDIGFYTLQVI | 111 | P40198 | |
| GSQAFLVSIYNEQGI | 111 | P20908 | |
| IQGSDVILTNTIYNQ | 91 | Q9Y5Q5 | |
| ALNATYIFNGLTVSV | 541 | Q9UBF2 | |
| QFNDNLYGTSIQSVR | 696 | Q92796 | |
| VNNYELNLGQITTIS | 441 | P48664 | |
| TILQYAQTTDGQQIL | 206 | P16220 | |
| IIFTISQGQIIDNYG | 451 | Q9UPI3 | |
| GAYTQVIFLARNNTI | 871 | P10253 | |
| NGQVFSLLSLGSQYQ | 51 | P28300 | |
| RQSLYGAQQEASVVQ | 96 | P31273 | |
| FSSSQGVEQVVLGLY | 46 | O95777 | |
| SAVLATYGFLVVANN | 11 | Q14314 | |
| NYVDSKVANLTFVVN | 171 | Q14314 | |
| LQLSQQLSGINAVFY | 276 | P11169 | |
| GVVDNYIQVDTTLSQ | 526 | Q9UEF7 | |
| AGLNFRITYSIVQTN | 191 | P01042 | |
| NDNLYGTSVQSVRFV | 751 | Q15700 | |
| AGIVQNLSTGSQSFY | 1396 | Q6ZMW3 | |
| NNLTFTGAINGDVYV | 1566 | Q6ZMW3 | |
| SFQVTSQNVGQLTVY | 86 | O60931 | |
| EYNLNFSGSSTIQEV | 206 | Q9UNN5 | |
| SESQVYISIGEFQNK | 496 | Q49AJ0 | |
| ELYQSSQNLGFISAS | 806 | P82279 | |
| SGANVTGFQLVNYTD | 246 | P42261 | |
| SLLIQNVTQEDAGSY | 106 | Q00888 | |
| GVTANLVLYLNSTNF | 51 | Q8IY34 | |
| VVAFIQQNISFLLGY | 216 | Q8IY34 | |
| LSYFLVDSAGQVVAN | 366 | Q9NTJ5 | |
| GQISNYVAAFVLGTE | 206 | O76082 | |
| VSGYLNLLANTIDNF | 216 | Q96H72 | |
| LFQYFADTLTAVVQN | 1121 | A3KN83 | |
| VAKQVFNSLTEYIQG | 3956 | P21817 | |
| VVNFGTLVANSKVYS | 146 | Q6ZTR5 | |
| TTVNSQVVSGGALYQ | 231 | Q96KN3 | |
| YNVSFISQTQVGDSQ | 481 | Q8TDX9 | |
| GSTQKNAQYVLVFDA | 281 | Q8IZK6 | |
| ATRVASYNQGIVVIN | 1151 | Q96JN8 | |
| GLNQVSSEVTSQLYA | 26 | Q8N137 | |
| LNFTNVTVQDTGQYT | 421 | Q9NT99 | |
| TLAGATYEEQVQSQI | 361 | Q32MZ4 | |
| SIFQSIEYAGQQDQV | 46 | O14830 | |
| LVDVSGTGTLFQSYQ | 736 | Q9Y5E1 | |
| DYNVQTSQGAILQAL | 786 | Q86XP0 | |
| TTINEIINYGVSSFV | 191 | Q8NHC4 | |
| SYNEIQLAVSSVIFV | 191 | Q9GZK4 | |
| TTVAYVINEASQGQL | 91 | Q99683 | |
| NIVQYLGSFSENGFI | 736 | Q99683 | |
| GSIFLVTGQQVDYSI | 401 | O00482 | |
| VTGQQVDYSIIASQA | 406 | O00482 | |
| QLGYVVQESGQNFST | 231 | P51575 | |
| EYSTGGNFQFNIISV | 1026 | O60469 | |
| GEVRSQNYQIAITIT | 76 | Q2WGJ9 | |
| TVFQRLSYNGQSSVV | 346 | Q8IZ73 | |
| SLDYDFQANQLTVGV | 146 | Q8N9I0 | |
| AFSLKYEQQTQSLVV | 361 | Q96C24 | |
| AAENVTIQTVSYGVQ | 111 | A6NDD5 | |
| NQGVTISVDLENGQY | 366 | O75445 | |
| GLVIQQVFDNGSIYN | 186 | Q8NHW5 | |
| DATVSQLSVILGYAN | 301 | P30872 | |
| FETVGISLANQQYVS | 461 | Q9HA77 | |
| FIAVTAYQNTDITQL | 366 | Q16650 | |
| ENGSLNIYSVQALTQ | 326 | Q96DN5 | |
| AEIVQYGVKNNTTFL | 576 | Q99985 | |
| RGSAYANIISQFAQT | 246 | Q86VL8 | |
| SENSVFQAVYGLQRA | 106 | Q6UWJ1 | |
| SAVDIQGLANYVIST | 171 | Q8N4U5 | |
| TQSRVNGSFYEILQV | 361 | Q14DG7 | |
| LLIQNVTQEDAGSYT | 106 | Q00889 | |
| RGYTTAAAVQVFVSQ | 216 | Q9BXS9 | |
| GEGLNVIQQTTRYFS | 271 | Q6NSW7 | |
| ITENTSQYQGVVVYS | 121 | Q9Y221 | |
| SLLIQNVTQEDAGSY | 106 | Q9UQ74 | |
| GLQTQNIQLDEYFSI | 221 | O75343 | |
| FLEVALGQYTSQGSV | 91 | P48065 | |
| LSQFDLNNYASVVII | 1646 | Q9Y520 | |
| TLNYVEKGFQISNVT | 221 | Q8IZM9 | |
| QSTDFYATGINQLIS | 656 | Q53H47 | |
| PIIQSSNSGQLFDYI | 446 | Q2M3M2 | |
| SNSGQLFDYIQAVTS | 451 | Q2M3M2 | |
| ASQGGQLFIYIQSIS | 441 | Q8WWX8 | |
| TYLVNQAAFDQRVAT | 126 | Q96PL2 | |
| TNTFGAINYVATEVF | 231 | P20701 | |
| SLLIQNVTQEDTGSY | 106 | Q13046 | |
| IYQNSTDVFQRLGSN | 766 | Q5T5J6 | |
| QGTQITVEDLFYNIA | 146 | P40692 | |
| DQEQQLEFGAVYTAT | 671 | Q8TCS8 | |
| QITSLAVNSSYGLVV | 631 | Q5T5C0 | |
| VVAVNGTLAYVSQQA | 536 | Q96J65 | |
| ISVGVYQNTEEAFTI | 96 | Q8IUC4 | |
| ITSELVSNGVQIYQF | 201 | Q14141 | |
| LASAFTEEQAVLYNQ | 221 | Q9UHB9 | |
| LNSLIGVSFNSVYTQ | 796 | Q8N122 | |
| FTAIYNSSGELINNI | 1276 | Q8N122 | |
| EQVQIFLNYTVAGSS | 231 | O43868 | |
| VDFTQDSNYLLTGGQ | 106 | Q9Y3F4 | |
| VVQYTQDLTGTGTQF | 431 | Q15047 | |
| ITVNYNGTLINETVF | 296 | P35498 | |
| YVNNNGIISFLKEVS | 71 | Q8TER0 | |
| DLIYGIFTTNVNSIA | 301 | Q13591 | |
| DQVYLNSQVVSAAIG | 261 | Q9BY15 | |
| YFQNTQGLIFVVDSN | 81 | P18085 | |
| TTILQYAQTSDGQQI | 146 | P18846 | |
| LQNYDAVINSQGITF | 146 | H7C241 | |
| IVQQLNESFSYFLGL | 126 | Q6EIG7 | |
| DAAIVAGIQYSDTQQ | 216 | Q7L0Q8 | |
| SADNNIVLYNIETGQ | 71 | Q12884 | |
| QQVGNEAYVIGLSSF | 1231 | Q96JI7 | |
| YVNNNGVVSFNVLVS | 66 | O75443 | |
| IAGVSVSQYEEQFVT | 271 | O14980 | |
| VDSAVNVGVTAYNIN | 591 | Q8N0X7 | |
| VSAYGNATSVQVGNI | 116 | Q8TCW7 | |
| FLSANALGNYVLVIQ | 56 | Q8N966 | |
| VLYVQQGLSSQAKFT | 16 | Q8TAG5 | |
| VALQDVGISLVNNYT | 2526 | Q96RL7 | |
| ASGSQYENVENLEFV | 451 | O15027 | |
| IYYTDSQLFGNQTVV | 136 | Q9Y5K1 | |
| IAVVNSVLFGVYSNT | 66 | Q8N413 | |
| QTVYAKSSGVFLQLQ | 226 | Q8N1Q8 | |
| QSVNQGFEAVYQLTR | 396 | Q15796 | |
| LLAQSVNQGFEAVYQ | 351 | P84022 | |
| QLIDGILYAFQEQTT | 891 | O75533 | |
| EQQYGQSSSRANFVI | 381 | Q9NYB5 | |
| LQYTIFTGQANVVSL | 416 | O15344 | |
| RINETYFTNVTVLNG | 341 | P20061 | |
| EQYLAESVVNFTGGQ | 211 | O15015 | |
| VVLVFVESAYSQLGQ | 86 | P52849 | |
| QSLLGTTGQVYDQAQ | 1471 | Q92576 | |
| DQFSFAENLYQIIGI | 546 | Q8IYM2 | |
| LSGVQQQLQAFTAYC | 341 | Q9H254 | |
| AVNYGLQVLDSAFEQ | 136 | Q9Y4E1 | |
| ISVGIYQNTEEAFTV | 11 | A8MT19 | |
| IYGVFTTNVNSIAAS | 371 | Q9P283 | |
| GVQQQLQAFSTYRTV | 336 | P11277 | |
| TVYNLGTAINTLSNE | 1636 | Q86WI1 | |
| TAYQVDIFAENNIGS | 706 | Q02763 | |
| QCGIQSSEYFQALVN | 2291 | P78527 | |
| TLTELVEYYTQQQGV | 71 | P29350 | |
| AQAQLLVTVEGSYVA | 496 | P07949 | |
| GLQSSNFGVNIQTYT | 231 | Q9UBW7 | |
| QYVISGEVAILNSTT | 906 | P11388 | |
| AVNYGLQVLDSAFEQ | 136 | Q641Q2 | |
| INNYFAVDTASAIAI | 221 | Q6NXT4 | |
| LGSSQSYLDVVQSNV | 256 | Q8IX04 | |
| TGYVTLLENANVSQL | 341 | O43149 | |
| ASGITSVLSQQAYVL | 356 | P0C7H9 | |
| QQLYIGSASAVAQVR | 501 | O15041 | |
| INSVIYELNVTAQAF | 561 | Q8WU66 | |
| ADINVTLVFQGYENT | 11 | Q9NSJ1 | |
| QTIQTLGQDFEYNES | 206 | Q6ZMW2 | |
| ITLNVNQGAEYSLSE | 2601 | Q9BXT5 | |
| YQSLQESVQVSLALF | 811 | Q96QU8 | |
| SAQSGQLFDYIQSIT | 446 | P13866 | |
| LTVVSFYQVAALQGD | 61 | Q9Y275 | |
| AYIQEITTADGQTVQ | 1201 | Q9H4Z2 | |
| EGTQDTFTNFQQVYL | 1806 | P01266 | |
| SVQYEGNINVSAAAL | 161 | Q08AF3 | |
| TAVNSLISKYGFQEQ | 201 | O94874 | |
| KLFTSGAVVDQQNVY | 61 | O95365 | |
| TNISSIQIQGDADYF | 566 | Q58DX5 | |
| LSEVLNSINSAQVYF | 766 | Q58DX5 | |
| GQLNFTGSVIYEAQD | 356 | P17050 | |
| QDYVTGLQTLISNVV | 891 | Q14CX7 |